CN102639081B - Tooth scaffold - Google Patents

Tooth scaffold Download PDF

Info

Publication number
CN102639081B
CN102639081B CN201080037027.8A CN201080037027A CN102639081B CN 102639081 B CN102639081 B CN 102639081B CN 201080037027 A CN201080037027 A CN 201080037027A CN 102639081 B CN102639081 B CN 102639081B
Authority
CN
China
Prior art keywords
support
tooth
bone
cell
bmp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201080037027.8A
Other languages
Chinese (zh)
Other versions
CN102639081A (en
Inventor
J·J·毛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Columbia University in the City of New York
Original Assignee
Columbia University in the City of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Columbia University in the City of New York filed Critical Columbia University in the City of New York
Priority claimed from PCT/US2010/039035 external-priority patent/WO2010148229A1/en
Publication of CN102639081A publication Critical patent/CN102639081A/en
Application granted granted Critical
Publication of CN102639081B publication Critical patent/CN102639081B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The present invention provides a kind of acellular mammalian tooth shape support, and it comprises chemotaxis, osteogenic, one-tenth dentine, becomes enamel or become cementum compound.Also provide for a kind of method replacing tooth in the mouth of mammal, wherein absence of tooth and in mouth position at disappearance tooth there is alveolus.Described method is included in alveolus implants the Acellular matrix with the shape losing tooth.Further it is provided that a kind of method preparing tooth scaffold.Described method includes the Acellular matrix synthesizing mammalian tooth shape and adds at least one chemotaxis, osteogenic, one-tenth dentine, become enamel or become cementum compound.

Description

Tooth scaffold
Cross-Reference to Related Applications
This application claims the U.S. Provisional Application No. 61/187,875 and on June 11st, 2010 submitted on June 17th, 2009 The rights and interests of the U.S. Provisional Application No. 61/354,164 submitted to;They are incorporated herein by reference.
Background of invention
The present invention relates to tissue engineering bracket.
Biomedical engineering and regeneration of tooth.Fall tooth generally to be caused by various oral diseases and physiology cause, including dental caries, Periodontal disease, damage, heredopathia and aging (Amar 2003, Philstrom2005, Kim 2006).Fall tooth may result in health and The misery of spirit, its self-respect that can reduce individuality and quality of the life (Amar 2003, Philstrom 2005, Kim 2006).Permitted Multi-form odontopathy and some medical condition the most uncontrolled diabetes raising fall tooth risk.For the treatment of anodontia, mesh Front selection is confined to use tooth transplantation thing and/or the fixed or movable prosthese of routine.
Recently, appearance and the development of biomedical engineering instrument has caused in the new patient care scope of medical domain.Example As, preliminary people's clinical experiment has been reported in the child of osteogenesis imperfecta at total body perfusion bone marrow stroma stem cell (BMSSC) or bone After myelocyte, bone formation level improves (Horwitz 2001, Horwitz 2002).Dental tissue engineering, material science and The progress proposition that stem cell biology field is recent, regeneration of tooth will be possible (Duailibi 2006).Additionally, there are in The recent qualification of the different mescenchymal stem cell (MSC) of tooth or cranium covering weave extends and is helping dental tissue (such as Dentine, cementum and periodontal ligament (PDL)) potential clinical benefit scope (Shi 2005) in regeneration.It is present in deciduous teeth with solid Dental tissue progenitor cell in the myeloid tissue of tooth can be used for making dentine and Regeneration of Alveolar Bone (Shi 2005;Zhang 2005). Additionally, the cell separated by both rat and pig tooth bud can be used for biological engineering anatomy correction corona, but have limited Predictability (Duailibi 2004, Honda 2005, Young 2002, Young 2005).
The most individual organ of tooth/periodontal complex.Although it is believed that this organ is relatively small, but its structure and growth Complexity is well recognized as.Tooth structure is made up of the organization type (enamel, dentine and cementum and dental pulp) of three kinds of calcifications. Dentine occupies the main body of tooth, and enamel and cementum are covered each by corona and tip portion.Periodontal tissue has tooth Supporting function, and be made up of cementum, periodontal ligament, alveolar bone and gingiva.Periodontal ligament is for passing through perforating fiber (Sharpey ' s fiber) makes the connection tissue that cementum is connected with alveolar bone.Periodontal ligament energy perception and buffering chew period Mechanical force.
Although tooth structure is complicated, but the progress of biomedical engineering technology has produced the tooth of two kinds of current employings more Generation method.First method is based on organizational project, and target is to make regeneration of tooth by inoculation stem cell in support biomaterial (Young 2002, Duailibi 2004, Honda 2005).This technology has shown the result likely of paradenlal tissue regeneration (Nakahara2006).Second method attempts to replicate or imitate the growth course (Nakahara 2006) that embryo's tooth is formed. The method utilizes the embryonal tissue's (tooth epithelium and tooth mesenchyme) gathered by mouse fetal and it should be understood that adjusts in embryo The principle (Ohazama2004, Hu 2006, Nakao 2007) of joint tooth development in early days.Use these methods, in many research In, Bioengineered dental gram is transplanted in the health of animal reservoir, described animal reservoir is usually rodent, Qi Zhongcun Necessary nutrient and oxygen is provided, so that organizing the formation of optimal (Nakahara 2006) at enough blood flows.
Stem cell and the challenge run into is used in tissue regeneration.Stem cell is be present in normal structure static Cell mass, it presents asymmetric fissional different characteristic, forms the progenitor cell of two kinds of daughter cells-new/dry thin Born of the same parents and the another kind of daughter cell (Hawkins 1998, Lin 1998) that the tissue broken up can be formed.Mesenchyme remote ancestor is thin for tooth Born of the same parents are the most identified and are characterized as dental pulp (Gronthos 2000, the Mooney 1996, Shi of people's deciduous teeth and teeth consolidating 2005).As previously mentioned, these the posteriori epitheliums being present in immature tooth bud and mesenchyme tooth steam cell/remote CFU-GM is proved to produce Bioengineered and anatomical correction, but makes containing enamel, dentine, marrow and alveolar bone Corona size miniaturization (Shi 2005;Zhang 2005).
Their regeneration potential of known Periodontal Ligament Cells, to cause formation lamina propria, cementum, bone and periodontal ligament (Melcher 1985, McCulloh 1985).For the subgroup of the cell by pericemental main outer planting syntaxy, demonstrate,prove Bright periodontal ligament stem cell in vitro forms the ability (Arceo 1991, Cho 1992) of the deposit of mineralising.Believe periodontal ligament Stem cell need suitable support to come in inductor to be formed bone, dentine and cementum (Gronthos 2000, Krebsbach1998).When periodontal ligament stem cell is incorporated in hydroxyapatite/tricalcium phosphate support and at mouse back Subcutaneous area in heterotopic transplantation time, form typical cementum/periodontal ligament spline structure (Seo 2004).Additionally, be proved I-type collagen in graft-positive periodontal ligament sample tissue is connected with the cementum being newly formed, it morphologically with pass through Wear fiber similar (Seo2004).
The recent development of tooth steam cell biotechnology and cell-mediated Muridae regeneration of tooth has encouraged researcher spy Study carefully the potential (Duailibi2004, Ohazama 2004, Shi 2005) of the regeneration of tooth of the work with suitable functional character.Can Use many different stem cell to make Muridae regeneration of tooth, with cooperatively form in vivo tooth structure (Duailibi 2004, Ohazama 2004, Young 2005).Additionally, when in the mice being transplanted to immunocompromised host, pass through type I collagen respectively And periodontal ligament stem cell (PDLSC) makes dentine/myeloid tissue and cementum/periodontal complex regeneration (Gronthos (DPSC) 2000, Seo 2004).But, due to people's dental growth and the complexity of growth, with being currently available that regeneration biological technology, whole Individual tooth structure (including enamel, dentine/marrow complex and periodontal tissue) is one as the regeneration of the functional entity of people and chooses War (Sonomaya 2006).
Research previously it has been reported the challenge (Duailibi using stem cell in the regeneration of dental tissue 2004, Young 2002, Young 2005).Have been accepted as, although in Bioengineered tooth formation, form multiple Minitype tooth Hat is possible, but the regeneration of the whole tooth of actual size runs into many challenges.These challenges are attributed to answering of tooth development equally Polygamy matter (Duailibi 2006, Tummers 2003).
The concept of cell playback.It has been proposed that the purpose of the conventional method of stem cell-inoculation is to imitate cell knot in support Structure and regenerate functional organization's equivalent in vitro or in vivo.Cell-derived self terminal organ or more undifferentiated source ratio Such as bone marrow (Schantz 2007).These methods are limited by problem, such as from the donor site sickness rate of cell collection With the heterogeneous quality of the transplantation site constructed in cell-scaffold organize the formation of (Schantz 2007).Therefore, cell playbacks Concept causes more concern at present.Cell playback purpose is to induce desired cell to playback to filling at specific anatomical site The support (Schantz 2007) of full cytokine.The method attempts tissue regeneration in vivo, and without cell-inoculation.Therefore, carefully Born of the same parents' playback can be that organizational project provides the enhancing of cellular processes and provides novel minimally invasive selection for tissue regeneration (Schantz2007)。
Based on discussed above, need the further exploitation of tooth scaffold.The present invention solves this demand.
General introduction
In some embodiments, it is provided that a kind of acellular mammalian tooth shape support.Described support comprises chemotactic Property, osteogenic, one-tenth dentine, become enamel or become cementum compound.
In other embodiments, it is provided that a kind of method replacing tooth in the mouth of mammal.Implement at these In scheme, absence of tooth and in mouth disappearance tooth position there is alveolus.Described method is included in alveolus implantation tool There is the Acellular matrix of the shape losing tooth.
Further it is provided that the method for preparation tooth scaffold.Described method includes that the nothing synthesizing mammalian tooth shape is thin Born of the same parents' support also adds at least one chemotaxis, osteogenic, one-tenth dentine, becomes enamel or become cementum compound.
Other purpose and characteristic are apparent from, and part is indicated below.
Accompanying drawing is sketched
It will be appreciated by those skilled in the art that the purpose that figures described below is merely to illustrate.These accompanying drawings are not intended to appoint Where formula limits the scope of this teaching.
Fig. 1 is the flow chart of the design of the research that display describes in an embodiment.
Fig. 2 uses 3D print system (Bioplotter for displayTM) support manufacture photo.Figure A shows and is used for producing The Bioplotter of supportTM;Rat Mandibular central incisor root (left) of figure B display manufacture and people's molar shape PCL-HA support (right);Figure C shows the ethylene oxide sterilizer for making support sterilizing;Figure D display somatomedin (SDF1 and BMP-7) processes Support;Figure E shows before transplantation for the support of the incubation of collagen cross-linking in the bracket;Figure F shows the grown factor Support with collagen gel load;Figure G shows at the support extracting groove and position, back is transplanted in rats.
Fig. 3 is the photo of people's mandibular molar shape support of the manufacture for transplanting at rat back.Hat and root are separately fabricated And merge later.Microchannel is obvious.
Fig. 4 is to extract lower jaw central incisor then to transplant the photo of root shape support in groove.The retraction of figure A display lower lip; The incision of figure B display gingival flap and reflection;The hurtless measure of figure C display lower-left jaw central incisor is extracted, the bone of the preservation of display channel Wall;Figure D shows the front tooth extracted and the comparison of root shape support;Figure E shows the support transplanted in extracting groove;Figure F display is sewed up And the main gingival flap closed.
Fig. 5 is the photo of people's mandibular molar shape support of subcutaneous transplantation in rat back position.The 2-that figure A display manufactures Cm otch;Figure B display produces subcutaneous pocket;Figure C shows in structural transplantation to bag;Figure D shows main Guan Bi.
Fig. 6 is the overall photo gathered of display lower jaw central incisor support.Figure A showed before gathering the most complete Wound healing;Figure B is displayed in proximity to the otch that support manufactures;The entirety of figure C display support (right) and adjacent front tooth (left) is adopted Collection.
Fig. 7 is the photo of the program showing the support collection for transplanting at position, back.Figure A showed before gathering complete Full wound healing;Figure B is displayed in proximity to the otch that support manufactures;The fascia encapsulating of figure C display support;What figure D display was reclaimed props up Frame.
Fig. 8 is the microphotograph that display selects the holder part of the dyeing for the region of histologic analysis.Figure A shows Three regions selected in lower jaw central incisor support;Figure B shows four regions selected in people's mandibular molar support.
Fig. 9 is the aobvious of the holder part of the dyeing of the tissue-mount interface of display door dental root shaped support in extracting groove Micro-photo (test and matched group).Figure A shows the microscope slide being described in the ingrown Feng Kesashi of Interface Bone (VK)-dyeing; Figure B display hematoxylin and the part of eosin (H&E)-dyeing, the intimate of cell wall is adapted to and integrates by its display support;Figure C shows Prove obvious angiogenesis and the higher enlarged drawing of soft tissue ingrowth between PCL-HA line.
Figure 10 is the cradle portion of the dyeing of the tissue-mount interface showing the people's mandibular molar shape support from position, back The microphotograph (test and matched group) divided.Figure A show online around and online between the angiogenesis of tissue and inwardly life Long;The higher enlarged drawing of figure B display explanation integration between support and encapsulating tissue.
Figure 11 is the microphotograph of the holder part of dyeing, and its display is from the representative diagram of the support extracting groove, and it shows Show the cell density difference of test bracket (figure A) and the crt bracket (figure B) without somatomedin.
Figure 12 is the microphotograph of the holder part of dyeing, and it shows the representative diagram of the support from position, back, its Display test bracket (figure A) and the cell density difference of the crt bracket (figure B) without somatomedin.
Figure 13 is the figure of display cell density difference between experimental group and transplantation site.GF+: test;GF-: comparison. " * ": p < 0.05.
Figure 14 is the microphotograph of the holder part of dyeing, and its display is from the representative diagram of the support extracting groove, and it shows Show the vessel density difference of test bracket (figure A) and the crt bracket (figure B) without somatomedin.
Figure 15 is the microphotograph of the holder part of dyeing, and it shows the representative diagram of the support from position, back, its Display test bracket (figure A) and the cell density difference of the crt bracket (figure B) without somatomedin.
Figure 16 is the figure of display vessel density difference between experimental group and transplantation site.GF+: test;GF-: comparison. " * ": p < 0.05.
Figure 17 is the microphotograph of the holder part of dyeing, and its display explanation is from extracting groove (figure A) and position, back (figure The representative diagram of the blood vessel diameter difference of support B).
Figure 18 is the figure of display blood vessel diameter difference between experimental group and transplantation site.GF+: test;GF-: comparison. " * ": p < 0.05.
Figure 19 is the microphotograph of the holder part of VK-dyeing, and its display is from the representative of the test pack support extracting groove Property figure, it shows mineralising.
Figure 20 is the microphotograph of the holder part of VK-dyeing, and its display is from the generation of the test pack support at position, back Table figure, it shows mineralising.
Describe in detail
The present invention is based partially on following being found surprisingly that, when being transplanted in alveolus, attraction shifting is grown by tooth tooth shape support The cell of support is to provide the tooth lived, even if do not have to provide cell for support exogenously.
Therefore, in some embodiments, it is provided that a kind of acellular mammalian tooth shape support.Described support comprises Chemotaxis, osteogenic, one-tenth dentine, one-tenth enamel or one-tenth cementum compound.Therefore transplant these supports, and there is no external source The cell that property is used.As set up in an embodiment, by migrating into the local cell of support, the shifting of the support of transplanting is grown and is filled Divide and carry out.By the chemotaxis being incorporated in support, osteogenic, one-tenth dentine, become enamel or become cementum compound, moving Grow and encouraged further.
Described compound can have any structure, includes but not limited to that albumen, oligopeptide, little organic molecule (that is, are less than About 2000mw or about 1000mw or about 500mw), the molecule of metal ion, carbohydrate or lipid.Chemotactic used herein Property compound be attract cell compound.Osteogenic compound is the compound encouraging the synthesis of new bone.Become dentine compound For encouraging the compound of new dentine synthesis.Becoming enamel compound is the compound encouraging tooth enamel synthesis.Become cementum Property compound be encourage cementum synthesis compound.
" support " used herein is for providing the structure of substrate to the growth of cell and/or being formed of tissue.Having of support Character be porous, biocompatibility and biological degradability, can support cell growth and as controlled gene-and egg The purposes (Murphy1999) of in vain-delivery vehicle.The three-dimensional macromolecular structure that support provides guides Bioengineered tissue Net shape (Murphy 1999).
The support of these embodiments can have the shape of any mammalian tooth.In some of these embodiments In, support has people's front tooth, people's canine tooth, people's bicuspid or the shape of people's molar.
Compound in these embodiments can be chemotaxis, osteogenic, one-tenth dentine, becomes enamel or become cementum Any compound of property.Limiting examples includes the somatomedin (PDGF) of platelet-derivative, endothelial cell growth factor (ECGF) (ECGF), conversion growth factor-β 1 (TGF-β 1), epidermal growth factor (EGF), hepatocyte growth factor (HGF), substrate are thin The factor-1 (SDF1) of born of the same parents-derivative, bone morphogenetic protein (BMP), TGF-β, GDF (GDF), Insulin-Like Growth factor-1 (IGF1), VEGF (VEGF), fibroblast growth factor (FGF), dentine matrix albumen, Dentine salivary gland albumen, bone salivary gland albumen, amelogenin or integrin.
In some embodiments, described compound is the SDF1 with chemotaxis character.SDF1 is chemotactic factor, it is believed that It supplements in (recruitment) stem cell and progenitor cell for tissue repair after wound is necessary (Kollet 2003).SDF1 also can the migration (Kim 1998) in chemotaxis indoor of the induction of hematopoiesis progenitor cell.Additionally, SDF1 for It is important that marrow stromal cell migrates to bone marrow, and the dose-dependency stimulated such as mescenchymal stem cell (MSC) response SDF1 moves Move shown (Win 2004).SDF1 also has anti-apoptotic character, and directly protection hematopoietic stem cell is from other somatomedin In the presence of the apoptosis effect (Herodin 2003) of γ-radiation.Additionally, the bootable mescenchymal stem cell derived from bone marrow (MSC) (Schantz 2007) is migrated towards SDF1.
In other embodiments, described compound is BMP.BMP2,6 and 9 are clearly the most effective of MSC osteogenic differentiation Reagent, and remaining BMP in terms of promoting to pay the osteoclast precursor of (commit) and osteoblastic terminal differentiation more Effectively (Cheng 2003).
In in some aspects of these embodiments, described BMP is BMP-7.Mesenchymal cell is being converted into bone by BMP-7 With the effect playing key in cartilage.BMP-7 process be enough to induce all bases of osteoblast differentiation in various cell types Because of label (Chen 2004).Noticing, BMP-7 has obtained the approval of Food and Drug Administration (FDA) to be made for people's clinic With.
Many researchs have investigated exogenous growth factor by the work in the carrier of delivery of growth factor to transplantation site With and behavior.Although carrier may not contribute the required any other factor that organizes the formation of, but still can be growth course Important component (Wozney 1990).One of function vector is to maintain the factor of transplantation site, and therefore improves its localized rich Degree.Carrier also serves as and wherein can form tissue and therefore help to limit the environment (Whang that wherein can form neoblastic region 1998).Collagen protein or synthetic vectors have been used as delivery vehicle, and their physicochemical properties and the microcosmic of generation Environment works in the result of induction.Carrier can be solid heterogeneity (such as, hydroxyapatite) (Kuboki 1995, Murata 1998), solid alloplasm (polyethylene polymer) material (Saito 1998, Isobe 1999) or spontaneous solidifying Glue (Sweeney 1995, Schwartz 1998), heterologous (Bax 1999, Viljanen 1997) or alloplasm source (Santos 1998) and combinations of the above (Alpaslan 1996).
One of function vector is to keep the factor at transplantation site and therefore provide its local concentration.Collagen matrices is just Remain up to the BMP of 65% during phase dipping, and in two stages it discharged: in the initial stage transplanted in a few hours and Depend on the second stage (Uludag 1999) of support and geometrical property thereof.Believe that BMP is not combined (Uludag with carrier 1999), but Physical entrapment is in its structure, and this makes some design be more beneficial for self-bone grafting (Tsuruga compared with other 1997).In the case of collagen protein sponge carrier, substantial amounts of collagen cross-linking and sterilizing methods affect BMP and precipitate, and with The resistance (Friess1999) of the sponge degraded of rear collagenase.Compared with polymeric matrices, collagen carrier can also result in regeneration Bone density improves (Cochran 1997).
BMP-7 plays the effect of key being converted into by mesenchymal cell in bone and cartilage.BMP-7 process be enough to induce All gene markers (Chen 2004) of osteoblast differentiation in various cell types.It is also noteworthy that arrive, BMP-7 obtains Approval to Food and Drug Administration (FDA) is used for people's Clinical practice.
In some of these supports, there is chemotaxis somatomedin and osteogenic, one-tenth dentine, become enamel or one-tenth Cementum somatomedin.In a specific embodiment, described chemotaxis somatomedin is SDF1, and described skeletonization Property, become dentine, become enamel or become cementum somatomedin be BMP-7.
The support of these embodiments can further include other bioactive molecule any, such as antibiotic or other Chemotaxis somatomedin or another kind of osteogenic, one-tenth dentine, one-tenth enamel or one-tenth cementum somatomedin.Implement at some In scheme, by adding such as human serum albumin (HSA), hetastarch, glucosan or combinations thereof, support is added By force.Known to those skilled in the art for the suitable concentration of these compounds of the application compositions, or without mistake Degree experiment is readily determined.
In support the concentration of compound according to character, its physiological action and desired treatment or the diagnosis effect of compound and Become.Therapeutically effective amount be usually therapeutic agent display intended effect and without the enough concentration of excessive toxicity.Some embodiment party In case, support comprise the BMP-7 of about 10ng/g-1000 μ g/g support in the bracket with about 10ng/g-1000 μ g/g support SDF1 is in the bracket.In a more particular embodiment, with about 100 μ g/g supports in the bracket, and SDF1 is with 100 μ for BMP-7 G/g support is in the bracket.
By any of method, compound can be mixed in support.In some embodiments, compound is embedded Gel (such as, the collagen gel being incorporated in the hole of support), as described embodiments.
Or, chemical modification method can be used for covalently bound for compound on the surface of support.Use known in this field Coupling agent (such as aldehyde compound, carbodiimide etc.), can be by the reactive functional groups of the surface functional group of support Yu compound Coupling, to form covalent bond.Additionally, spacer molecule can be used for the reactive base of displaced surface reactive group and biomolecule Group so that these molecules are the most more flexible.Other class being interiorly or exteriorly connected by biomolecule with substrate It is known to a person skilled in the art like method.
Or by system based on carrier (such as encapsulating vehicle), compound can be incorporated in Medium Culture or substrate. These vehicles can be used as slow releasing composition.Such as, can be by micro-for somatomedin encapsulating, to provide the stability strengthened and/or to prolong Long delivery.Encapsulating vehicle includes but not limited to microgranule, liposome, microsphere etc., or any of above combination, to provide not Desired release profile in proportion.Other method of the controlled-release delivery of reagent is that professional and technical personnel is known.Additionally, Can be by these and other system in combination and/or amendment, so that integration/release that reagent is in the substrate is optimal.
Polymeric microspheres can use the polymer production naturally occurring or synthesizing, and is that size is at 0.1-500 μ m Interior particle system.Polymeric micelle and polymer waterfloocling (polymeromes) are passed with being polymerized of microsphere similar characteristics for having Send vehicle, and also can promote that the encapsulating of compound described herein and substrate are integrated.Microsphere for various payload The manufacture of body, encapsulate and stablize within the skill of the art (for example, see, Varde&Pack (2004) ExpertOpin.Bio1.4(1)35-51).By the type of polymer, polymer molecular weight, copolymer form, join micro- The excipient of spheroid preparation and sized micro-spheres, can adjust the rate of release of microsphere.Can be used for being formed the polymer of microsphere Material includes PLA, PLGA, scribbles the PLGA of DPPC, DPPC, DSPC, EVAc, gelatin, albumin, chitosan, glucosan, DL- PLG, SDLM, PEG (such as, ProMaxx), hyaluronate sodium, Diketopiperazine derivative (such as, Technosphere), phosphoric acid Calcium-PEG granule and/or oligosaccharide derivatization DPPG (such as, Solidose).Can such as use the single emulsion process of water/oil, water-oil- The double emulsion process of water or lyophilizing realize encapsulating.Available several industry wrapper technology is (such as,Alkerme)。
Liposome can be additionally used in be integrated compound with support.The reagent carrying capacity of liposome and rate of release can depend on In lipid composition, size, electric charge, drug/lipid ratios and delivering method.Conventional liposome is by neutral or anion lipid (naturally occurring or synthetic) forms.Conventional lipid is lecithin, such as phosphatidylcholine, PHOSPHATIDYL ETHANOLAMINE, sphingomyelins, phosphatidyl Serine, phosphatidyl glycerol and phosphatidylinositols.Liposomal encapsulated method is (Galovic et al. commonly known in the art (2002) Eur.J.Pharm.Sci.15,441-448;Wagner et al. (2002) J.Liposome Res.12,259-270). The liposome of targeting and reactive liposome also can use with reagent and substrate combination.The liposome of targeting has targeting ligand, The monoclonal antibody being such as connected with their surface or lectin so that with specific receptor and/or cell type phase Interaction.Reactive or polymorphic liposome includes the liposome of wide scope, and their common property is when specific phase interaction Change their phase and structure (such as, pH-sensitive liposome) with tending to afterwards.For example, see Lasic (1997) Liposomes in Gene Delivery (liposome in gene delivery), CRC Press, FL).
Any material that the support of these embodiments can use professional and technical personnel there have been manufactures.Suitably base Material is such as in following discussion: Ma and Elisseeff edits (2005) Scaffolding in Tissue Engineering (at organizational project medium-height trestle), CRC, ISBN 1574445219;Saltzman (2004) Tissue Engineering: EngineeringPrinciples for the Design of Replacement Organs and Tissues (tissue work Journey: replace the engineering philosophy of the design of organ and tissue), Oxford ISBN 019514130X.For all or part of support The limiting examples of the material come in handy include Polyethylene Glycol, polylactide, polyglycolic acid, lactide coglycolide Copolymer, poly-(caprolactone), condensing model, polyglactin, Merlon, polyamide, condensing model, polyamino acid, poly-ortho acid Ester, poly-acetal, polybutylcyanoacrylate, polyphosphazene, degradable polyurethane, polyacrylate, ethane-acetic acid ethyenyl ester are poly- Compound and other acyl group substituted cellulose acetate salt and their derivant, polyurethane, polystyrene, polrvinyl chloride, poly-fluorine Ethylene, polyvinyl pyrrolidone, poly-(vinyl imidazole), chlorosulfonated polyolefin, poly(ethylene oxide), polyvinyl alcohol, TeflonNylon, agarose, alginate (such as, calcium alginate gel), fibrin, Fibrinogen, fibronectin, glue Former albumen (such as, collagen gel), gelatin, hyaluronic acid, chitin and other suitable polymer and biopolymer, Or above analog, mixture, combination and derivant.
In some embodiments, support is by the compositions manufacture comprising bone conduction (osteoconductive) material.Bone The limiting examples of conduction material is hydroxyapatite (HA).The biocompatibility excellent due to HA and high bioactivity, it Have been used as bone substitute many years (Liao2006, Nebahat 2006, Lijun 2006, Wei 2003).
Although HA has good biological activity and bone conductibility, but it is highly brittle and intrinsic tensile property is poor.Cause This, in some embodiments, combine HA Yu ε-polycaprolactone (PCL).Owing to PCL needs several years just degradation in vivo also And for biocompatibility, relatively inexpensive and can obtain in a large number, it is good bone holder material (Rich 2002, Kim 2004). The combination (PCL-HA) of PCL and HA provides the desired combination (Patcharaporn of biological activity, biological degradability and intensity 2005, Rezwan 2006, Landis 1995, Ziv 1994).Think the material of complex PCL-HA have biocompatibility, Cell-bond, the optimal support character (Zhao 2008) bred and break up.In some embodiments, support comprises about 80% Weight polycaprolactone and the mixture of about 20% weight hydroxyapatite.In other embodiments, support comprises about 60% weight Amount polycaprolactone and about 40% weight hydroxyapatite to about 95% weight polycaprolactone and about 5% weight hydroxyapatite times What quantity.Such as, support can include about 70% weight polycaprolactone and about 30% weight hydroxyapatite.Real as another Example, support can include about 90% weight polycaprolactone and about 10% weight hydroxyapatite.
In some embodiments, support has high porosity.This loose structure be new osseous tissue cell migration, Bonding and growth provide space (Gazdag 1995, Rezwan2006, Mano 2004, Shin 2003, Kim 2001, Leong 2003)。
The hole of support and passage can be engineered, to have various diameter.Such as, the hole of support can have a few micrometers to number The diameter range of millimeter.In some embodiments, the hole of host material includes microchannel.The usual average diameter in microchannel is about 0.1 μm-about 1,000 μm, such as, about 50 μm-about 500 μm (e.g., from about 100 μm, 150 μm, about 200 μm, about 250 μm, about 300 μ M, about 350 μm, about 400 μm, about 450 μm, about 500 μm or about 550 μm).It will be appreciated by those skilled in the art that microchannel diameter Distribution can have any distribution, including normal distribution or nonnormal distribution.In some embodiments, microchannel is host material Naturally occurring feature.In other embodiments, by microchannel through engineering approaches, to be present in host material.
In some embodiments, described compound is embedded in the gel in microchannel.Any gel can be used for this mesh 's.In some embodiments, described gel is collagen gel.
In various embodiments, support comprises atresia corona (cap) further.This corona provides further for support Intensity and prevent infect.Described atresia corona may simply be the material identical with the remainder of support, except not having hole. Or, described atresia corona can be different material, such as, typical tooth corona material, the most ceramic or golden.
The method that in the mouth of mammal replace tooth is also provided herein.In these embodiments, absence of tooth And there is alveolus in the position at disappearance tooth in mouth.Described method is included in alveolus to implant has the shape losing tooth Acellular matrix.
Use multiple method to manufacture porous support, including granule leaching, gas foaming, electricity spin, lyophilization, by starching Material makes ceramic foam and forms polymeric sponges (Mikos 1994, Mooney 1996, Qing 2002, Sylvain 2006).So And, by the support using these methods to prepare, there are in terms of the structure and interconnectivity of control hole some shortcomings, this can limit They application (Yeong 2004, Tan 2003) in terms of Premeabilisation of cells in organizational project.
In some embodiments, described method farther includes by computer-aided design (CAD) preparation disappearance The model of tooth, and use bioplotter to synthesize described support.This method can provide has high porosity with the most mutual The support of connection property.As described by an embodiment, can prepare and there is controlled and reproducible porosity and good limit Three-dimensional (3D) support of 3D microstructure.Have pointed out rapid prototype manufacturing (RP) method, such as fused deposition modelling, selectivity Laser sintered, 3D prints, multistage injection solidifies and 3D draws (Hutmacher 2001, Moroni 2006).
The key feature of rapid prototype manufacturing is that solid free form manufactures (SFF) method: cut by 3D computer model The sequence of stratification, it constructs complicated object for successively.Induced by the solidification of melt, layer photopolymerization or use laser beam Sintering one of (selective laser sintering) or particular adhesive make granule bonding payzone in next life (Landers 2002).Recently, Introduce the RPM Systems (Bioplotter of specializationTM, EnvisionTec, Germany) so that can design and manufacture tool There is the support with anatomic shape of different internal structure, it is thus possible to accurately control hole size, porosity, permeability and rigidity (Landers 2002;Landers 2005).Use BioplotterTMFor manufacturing the former of tissue-specificity PCL-HA support Type manufacture method needs the 3D shape information of destination organization or tissue defects, and these can pass through computerized tomography roentgenography Or nuclear magnetic resonance (MRI) obtains (CT).When lacking tooth and having homologue at the opposite side of mouth, this homologue can be used as mould Type carrys out the tooth design support for losing.
Information derived above is used subsequently to by CAD design functional support, and transfers to BioplotterTMSystem. Within the system, BioplotterTMMachine-melt timbering material, and on collecting board, successively distribute timbering material (such as, PCL- HA).As a part for design, hole, such as microchannel can be produced.The 3D support manufactured by RP system causes significant cell Infiltration, and therefore there is the character (Heo 2007) of ideal stent.By for patient provide tissue-specific anatomical shape with And for nutrient transport and angiopoietic optimized internal microstructure, what these 3D supports can have a clinical practice can Energy.Other details of these methods provides in PCT Publication WO2009006558, and this announcement is incorporated by reference.
Further it is provided that a kind of method preparing tooth scaffold.Described method includes synthesizing mammalian tooth shape Acellular matrix also adds at least one chemotaxis, osteogenic, one-tenth dentine, becomes enamel or become cementum compound.? In some embodiments of these methods, the tooth that the shape picture of described tooth lacks in mammal, and described method Farther include the model by computer-aided design (CAD) preparation disappearance tooth and with described in bioplotter synthesis Support.When the tooth of disappearance has homologue (such as, molar) in mouth, described method farther includes the mortar carrying out being similar to The CT scan of tooth, such as, at the opposite side of mouth, wherein CAD utilizes the CT scan data of second molar to design described support.
In some embodiments of these methods, described compound is the somatomedin (PDGF) of platelet-derivative, interior Skin cell growth factor (ECGF), conversion growth factor-β l (TGF-β 1), epidermal growth factor (EGF), hepatocyte growth factor (HGF), the factor-1 (SDF1) of stromal cell-derivative, bone morphogenetic protein (BMP), TGF-β, GDF (GDF), insulin-like growth factor-i (IGF1), VEGF (VEGF), fibroblast growth factor (FGF), dentine matrix albumen, dentine salivary gland albumen, bone salivary gland albumen, amelogenin or integrin.
In other embodiments, described support is by the compositions manufacture comprising bone conduction material.As discussed above, The example of available bone conduction material is hydroxyapatite.Other example is ε-polycaprolactone as discussed above and hydroxyl phosphorus The mixture of lime stone.In the various embodiments of these methods, support comprises diameter microchannel between 50-500 μm.? In other embodiments, support comprises atresia corona further.
In some embodiments, for the expression composition of certain embodiments of the present invention is described and claimed as Amount, the numeral of character such as molecular weight, reaction condition etc. are interpreted as being modified by term " about " in some cases.Real at some Executing in scheme, described term " about " is for illustrating that this value includes the standard deviation of the meansigma methods for the device or method measuring this value Difference.In some embodiments, the numerical parameter described in printed instructions and claims is approximation, and it can root Become according to seeking the desired character that obtained by specific embodiments.In some embodiments, be considered as being reported has Imitate the numeral of number and apply the common technology that rounds up to explain described numerical parameter.Although describing some enforcements of the present invention The numerical range of the wide scope of scheme and parameter are approximation, but the numerical value described in a particular embodiment essence as far as possible cuts ground Report.The numerical value presented in some embodiments of the present invention can comprise by the mark found during test is measured accordingly at them Some error that quasi-deviation necessarily causes.Quoting of numerical range is provided merely as individually mentioning and falls into the every of this scope herein The method for simplifying of individual independent value.Unless otherwise specified herein, otherwise each single value is incorporated in description, just looks like herein In be individually recited as.
In some embodiments, unless otherwise indicated, otherwise describe specific embodiments context in (particularly In the context of some claim) term " " that uses may be interpreted as covering odd number and plural number with " being somebody's turn to do " and similar quoting Both.In some embodiments, the term "or" (including claim) herein and using is for referring to "and/or", unless clearly Explanation is only to refer to that substitute or substitute are mutually exclusive.
Term " comprises ", " having " and " including " is open connection verb.Any shape of these verbs one or more Formula or tense, such as " comprise ", " comprising ", " having ", " having ", " including " and " including " are also open.Such as, " bag Contain ", any method of " having " or " including " one or more steps be not limited to that only there are those one or more steps, and And also can cover other step do not enumerated.Similarly, " comprise ", any group of " having " or " including " one or more feature Compound or device are not limited to only have those one or more features, and can cover other feature do not enumerated.
All of method described herein can use any suitable order to carry out, unless herein additionally explanation or on Negate the most clearly.Any and all embodiment of the pass offer of some embodiment in this article or exemplary language are (such as " such as ") use is only intended to preferably illustrate the present invention, and the scope of the present invention requiring in addition that protection is not produced limit System.Language is not had to should be interpreted that the key element implementing necessary any failed call protection of the explanation present invention in the description.
The confession of present invention disclosed herein selects the packet of key element or embodiment to should not be construed as restriction.Each group membership can Relate separately to and claim or carry out any combination with other member of this group or other key element of finding herein.For side Just or the reason of patentability, the one or more members in group may be included in a group or delete from a group.When going out Incumbent what is the most this when including or delete, and description can be considered the group comprising amendment in this article, thus realize will in appended right Seek the written description that all marlcush group of middle use are closed.
All of publication, patent, patent application and other list of references quoted in this application are for all purposes It is incorporated herein by reference, and as each single publication, patent, patent application or other list of references tool Body with illustrate individually identical by quoting in full the degree of combination for all purposes.Quoting of reference herein should not It is construed as an admission that the prior art that this list of references is the present invention.
Describe in detail the present invention, it is obvious that without departing from the present invention defined in the appended claims In the case of scope, revise, change and equivalent embodiments is possible.Furthermore, it is to be understood that all embodiments in the disclosure There is provided as non-limiting example.
Embodiment
There is provided following non-limiting example to further illustrate the present invention.It will be understood by those skilled in the art that following Technology disclosed in embodiment represents the method that inventor finds good running in an embodiment of the present invention, therefore can recognize For constituting the embodiment of its embodiment.But, in view of the disclosure, it will be understood by those skilled in the art that without departing from the present invention In the case of spirit and scope, disclosed specific embodiments can carry out many changes and still obtain similar or similar Result.
Embodiment 1: by the regeneration of the anatomy correction tooth that cell playbacks
One of odontogical basic mission is for recovering tooth structure that is ill, loss and that lose.At present, to falling tooth Conventional treatment includes that the prosthodontia using or not making the tooth transplantation thing surgically placed is treated.Although having reported tooth The high success rate of tooth graft, but it is not without complication, such as loose, infection and bone loss.Recently, in doctor and science Exist in Jia and biomedical engineering prompting (cue) can be used to make single tooth structure or the common aspiration of whole regeneration of tooth. But, this emerging field encounters several obstacle, and maximum of which is the complexity of regeneration and tooth structure form.This research carries Go out to use Bioengineered tooth scaffold and by delivery is known, the somatomedin that tooth development is important set up whole tooth The regeneration of tooth organ.Use BioplotterTMMachine, by the coalition of ε-polycaprolactone and hydroxyapatite (PCL-HA) The rapid prototype manufacturing of layer deposition, first manufactures full-scale people's tooth scaffold.Concurrently, also Sprague Dawley is built with 3D The support of the lower jaw central incisor root shape of rat.This support is subsequently with the factor-1 (SDF1) and the Bones morphology of stroma cell derivative There is albumen 7 (BMP-7) perfusion.There are 22 Spraque Dawley rats, in test group and matched group each 11.Big at every In Mus, at position, back subcutaneous transplantation people's mandibular molar shape support, and surgical operation extract two lower jaw central incisor it After one in extracting groove transplanting rat lower jaw door dental root shaped support.Test pack support SDF1 and BMP-7 dipping, and matched group props up Frame does not contains somatomedin.After the transfer 9 weeks time gather the support of all of transplanting, and Histological evaluation's tissue ingrowth, thin Born of the same parents' infiltration, angiogenesis and mineralising.
Material and method.Before starting this research, obtain Columbia University's association's animal care and use committee (IACUC) approval.This research uses the lower jaw central incisor of 12 week old male Sprague Dawley Rats to extract groove and subcutaneous Position, back (Charles River, NY).All of position accepts PCL-HA support.Have 22 SD rats, they are random It is divided into two groups: test group and matched group, each group in two groups has 11 rats.As it is shown in figure 1, respectively every rat is given Give identifier-#1 to #11 and #12 to #22-test group and matched group.After point of purchase, during one week laundering period, rat is become To being maintained in 12 hours light/dark cycles, and before the surgical procedure of structural transplantation, random feeding rat chow (Rodent Laboratory Chow 5001, Ormond Veterinary Supply, Ontario, Canada) and water.Table 1 Summarise the number of holders of seminar and transplanting.
Table 1. seminar and the number of holders of transplanting
E=extracts groove location and transplants;The subcutaneous back of D=is transplanted.
Each Test sites (lower jaw central incisor extracts groove and subcutaneous back) of every rat is accepted one by surgical operation Individual PCL-HA support.Extract groove location and accept the support of the root as lower jaw central incisor.Position, back acceptor's mandibular molar shape The support of shape.Support SDF1 and the BMP-7 dipping transplanted in test group rat, and matched group accepts only have collagen protein The support of gel.All rats keep 9 weeks at surgical site infections, gather support subsequently for lab analysis with quantitative.
Prepared by support.Use 3D print system (BioplotterTM, Envision TEC, Gladbeck, Germany), pass through Layer by layer deposition manufactures the PCL-HA support (Fig. 2 A, B) of Rat Mandibular central incisor root shape and people's mandibular molar shape.This is multiple Compound is by 80% weight polycaprolactone (PCL) (Mw~65,000, Sigma, St.Louis, MO) and the hydroxy-apatite of 20% weight Stone (HA) (Sigma, St.Louis, MO) forms.PCL-HA is melted in room at 120 DEG C, and by 27-gauge metal pin (DL technology, Haverhill, MA) distributes, to produce the line and the microchannel (Fig. 3) of interconnection being clipped in the middle.Owing to making It is one piece of difficulty run in it manufactures continuously, individually produces hat and the root architecture of people's mandibular molar shape support, and melt subsequently Close to form whole tooth (Fig. 3).All of support includes what the interlock of the PCL-HA line by a diameter of 200 μm produced The microchannel (Fig. 3) of a diameter of 200 μm.The macromole 3D structure of support is intended to the formalness promoting to form final result, and The target of the internal structure with microchannel is to provide and occupies the space with tissue ingrowth for cell.Propping up of all manufactures Frame is sterilizing 24 hours in ethylene oxide sterilizer, subsequently with the collagen gel (test group) containing SDF1 and BMP-7 and Collagen gel (matched group) without somatomedin processes (Fig. 2 C).Use aseptic experiment room technology, at laminar flow hood In carry out the process of support.
For test group, by 100ng/ml stromal cell-derivative factor-1 (SDF1) (R&Dsystems, MN) and 100ng/ml bone morphogenetic protein-7 (BMP-7) (R&D systems, MN) 2mg/ml neutrality cattle I-type collagen (R&D Systems, Minneapolis, MN) middle combination.Subsequently somatomedin-collagen solution is filled into In the microchannel of PCL-HA support, and cross-link 1 hour in moist cultivating container at 37 DEG C.At PBS, 10X PBS, NaOH In mixture, the collagen gel of preparation load SDF1 and BMP-7, is summarized in table 2.SDF1 is selected based on work above Dosage with BMP-7.Chemotaxis measures and shows, mescenchymal stem cell grows towards SDF1 stimulus object, at 100ng/ml There is under concentration maximum chemical chemotaxis (Schantz 2007).The BMP-7 concentration of 100ng/ml has shown and has effectively facilitated skeletonization Cell grows (Laflamme 2008) in collagen carrier.The most unsupported any somatomedin of matched group support. But, use identical mode described with test group, at surgery operation consent, empty collagen gel is filled in microchannel.
Table 2. is delivered to test the details of the growth factor solution in pack support.
Inclusions Amount (ml)
10X PBS 1
1N NaOH 0.14
PBS 4.86
Collagen protein I 2(5mg/ml)
BMP7 1(100ng/ml)
SDF1 1(100ng/ml)
Cumulative volume 10
Surgical procedure.Buy 12 week old Sprague Dawley rat (CharlesRiver, NY), and allow them fit Should about 1 week.The all of rat mixture of KET (80mg/kg, IP) and xylazine (5mg/kg, IP) is anaesthetized.In journey Carry out the degree of depth of Monitored anesthesia by pinching toe (toe-pinch) during sequence;And when needed, individually give KET (all The 1/3:25mg/kg of dosage, IP), with on-demand holding depth of anesthesia.Pulse-oximeter device is used at surgery intra-operative Monitoring pulse rate and oxygen saturation level.
Surgery operating technology between the two groups is identical (Fig. 4,5).Carry out careful hurtless measure surgical operation and extract lower jaw Central incisor, immediately followed by transplanting root shape support (Fig. 4 C, D, E) in extracting groove.Use periosteotome (Periotome) as far as possible Carry out extracting program, the bone wall (Fig. 4 C) of careful retention groove hurtless measure.During transplanting structure, the careful quilt by this structure Move and be suitable for keeping lip wall (Fig. 4 E).After the transfer, propose (advance) limb (flap) and close for main, and each groove (polyglylactin suture material (Vicryl is used by one or two single (single-interrupt) sewn closed of interrupting 5-0, Johnson and Johnson, NJ)) (Fig. 4 F).
At the position, back of identical rat, the subcutaneous transplantation (Fig. 5) of the people's mandibular molar shape support being prepared.Place The long horizontal cut of 2-cm, and use sharp scissors for surgery make subcutaneous area relax and become bag (Fig. 5 B).In subcutaneous generation Transplanted Human mandibular molar shape support (Fig. 5 C) in Dai.This position with polyglylactin suture material (Vicryl 5-0, Johnson and Johnson, NJ) close, it is ensured that the bubble (Fig. 5 D) not retained before Guan Bi.Place breaking joint in multiple list Close, for main Guan Bi.
After completing transplanting program, give fourth the third promise coffee (0.05mg/kg, IP) and be used for pain relieving, relocate to subsequently move Thing intensive care unit.During the convalescent period of 3-5 days, veterinary technician closely monitor rat, and light/dark at 12 hours Cycle is maintained in the single cage taken, and random feeding rat chow (Rodent Laboratory Chow 5001, OrmondVeterinary Supply, Ontario, Canada) and water 9 weeks, euthanasia subsequently.During these 9 weeks, in routine On the basis of closely any infection of monitoring rat or disease indication.When observing this sign, carry out suitable treatment.Monitoring The continued growth of residue front tooth, to avoid malocclusion and the malnutrition caused.When producing instruction, clamp tooth, to hold Easily chew.When surgical site infections 9 weeks, by every rat humanity euthanasia, the pentobarbital of overdose is immediately used to note Penetrate IP to be acquired.
Gather and laboratory procedure.Before gathering, it should be apparent that keep lower jaw central incisor to extract the gingiva group on groove Knit, and do not expose support (Fig. 6 A).Position, back displays that its optimal wound healing (Fig. 7 A).
Monoblock (en bloc) gathers the support in lower jaw, including remaining adjacent center front tooth and alveolar bone (Fig. 6).Return Receive back bracket, around fascia encapsulating support (Fig. 7).The structure of all collections is stored in 10% formalin, transports subsequently Transport to histology experiment room, prepare the hematoxylin with each sample and eosin (H&E) and Feng Kesashi for 5 μm-thickness microscope slide (VK) dyeing.
Cell playback, vascularization and mineralising quantitative.Cell playback, vascularization and mineralising quantitative based on seminar And cell density between transplantation site, angiogenesis (blood vessel number and diameter) and existing mineralising is observed any Difference.
By do not know which rat belong to which group blind trier carry out quant program.Checking each support Microscope slide before, determine which region contributes to histological data analysis.Agree to check the support of preparation on microscope slide Corona 1/3rd, middle 1/3rd and the zone line of most advanced and sophisticated 1/3rd, as shown in Figure 8.Therefore, by extracting groove collection Support have three evaluate regions (Fig. 8 A), and the support gathered by position, back due to exist two roots and there are four The region (Fig. 8 B) evaluated.Numeral research microscope (LeicaDM6000, Leica, Switzerland) is used fully to examine under 100X amplifies Test each microscope slide.Microscope slide is carried out Digital photographic.Use the software program Leica that microscope provides ApplicationSuite (LAS) carries out the quantitative of cell and blood vessel in the region agreed to.Later counting was converted into quantity/ mm2.Computer software programs (Photoshop CS) are used to measure blood vessel diameter and be converted into millimeter (mm).Also evaluate whether to deposit In mineralising.
Statistical analysis.Computer program (Microsoft Office Excel 2007) is used to carry out all of statistical Analysis.For foregoing each variable, calculate average and standard deviation value.Carry out t-inspection, to measure at two experimental grouies Between and significance level between transplantation site.P-value < 0.05 is considered significant.
Result
Organizational integration with PCL-HA support.As in Fig. 9 and Figure 10 it will be apparent that, from two transplantation sites of two groups All of support shows, tissue-mount interface region shows the tissue of relative close and adapts to support.Do not appear in two groups it Between there is any significant difference, this is unrelated with transplantation site.But, the micro-characteristic of integration seems at two transplantation sites Between different.For the support in extracting groove, interface is characterised by that significant bone adapts to support, may serve as a contrast containing fiber In.The bone growth (Fig. 9 A, B) that some interfaces are presented between the line of support.It addition, deposit in the interface of support and cell wall Positive evidence (Fig. 9 C) at angiogenesis and soft tissue ingrowth.Seem to be organized in around PCL-HA line and at PCL-HA (Fig. 9 C) is grown between line.Tissue is also along bone cell wall (Fig. 9 C).Position, back display interface has well in support Soft tissue ingrowth (Figure 10 A, B) in region, portion.
Premeabilisation of cells and density.The previous research utilizing PCL-HA support is proved to comprise around the line of PCL-HA support Premeabilisation of cells and propagation (Heo 2007).As shown in FIG. 11 and 12, between test group and the matched group of each transplantation site There is significant cell density (cell/mm2) difference of level.Figure 11 describes by the representative district extracting the support that groove reclaims Territory, and Figure 12 represents the region from position, back support, test group respectively and matched group.By test pack support observe thin Born of the same parents' density, much larger than the cell density-p=0.049 observed by matched group and p=0.001, extracts groove location and back respectively Position.By the support extracting groove recovery, there is the cell mass-p=0.016 more more dense than the support reclaimed by position, back and p= 0.002, test group respectively and matched group (Figure 13).
Angiogenesis.In the support from all collections of two experimental grouies, angiogenesis is substantially (Figure 14,15).Logical Often, compared with matched group, the degree (blood vessel/mm of the angiogenesis observed in test pack support2) bigger, this and transplanting portion Position unrelated-p=0.011 and p=0.002, extracts groove and position, back (Figure 16) respectively.But, from the support extracting groove The density observed seems overall bigger, regardless of its statistics non-limiting-p=0.222 between group and p=0.095, surveys respectively Examination group and matched group (Figure 16).
Blood vessel diameter (μm) in the transplantation site of back is more than-p=0.028 and p=0.022 in extracting groove, respectively Test group and matched group (Figure 18).But, between experimental group, do not add up difference-p=0.426 and p=0.732, pull out respectively Go out groove and position, back (Figure 18).The representative photo of microscope slide shows, and by compared with extracting the support of groove collection, it appears that by The blood vessel diameter much bigger (Figure 17 A, B) of the support that position, back gathers.As shown in figure 18, in back bracket, at matched group Inside there is significantly larger blood vessel diameter meansigma methods, but this difference is not up to statistical significance (p=0.732).
Mineralising.Only in test pack support, observe mineralised zones (Figure 19, Figure 20).Carry out self-test group and extract groove and test The support of group back transplantation site shows mineralised zones in Feng Kesashi (VK) microscope slide.At two kinds of transplantation sites, well See that mineralising enters support, and at tissue with mount interface region without mineralising.
Discuss
Cell transplantation is acquiescence (default) strategy for the treatment of based on cell, and it includes transplanting or injection culture-swollen Swollen or modified tissue remote ancestor or the tissue (Mooney 1996) formed completely.But, the adult cell of culture-expansion Therapeutic engraftment has several critical obstacle, life-span limited during being included in the culture period of prolongation, slowly propagation and Lost cell phenotype (Muschler et al. 2004).Therefore, especially for substantive in vitro (ex vivo) cell manipulation of needs Those, suspected technology and the economic feasibility (Muschler et al. 2004) of cell delivery delivery method.Recently, more and more Pay close attention to and playbacked by cell, then make tissue regeneration (Stosich etc. frequently by the celliferous form in elaborately planned sky occurs People 2007).Cell playback is defined as actively being added to by endogenous cell in predetermined anatomy compartment, and represents at tissue again Also in the method (Quesenberry 1998) of research in life.Similarly, this strategy of Schantz is called " cell playback ", and will It is defined as " playback of position-guiding that induced tissue is formed in the support of cytokine-load of local stem cell " (Schantz 2007).In many adult tissues, stem cell is playbacked and migrates the replacement for ongoing mature cell Regeneration with damaged cell is critical (Laird et al. 2008).
This result shows, the interconnecting microchannel (diameter 200 μm) produced by layer by layer deposition PCL-HA (diameter 200 μm) The tissue that internal structure contributes to interface zone is intimate adapts to support, is followed by host cell and successfully playbacks inside with blood vessel Grow into extensive (~17mm) support.Support containing SDF1 and BMP-7 promotes host cell infiltration.
The factor-1 (SDF-1) of the stromal cell secreted in bone marrow microenvironment by stromal cell-derivative is by expressing it The progenitor cell of homoreceptor Gro-beta-T receptor 4 (CXCR4) supplement and promote cell playback in play necessity work With (Vandervelde 2005).CXCR4+ positive cell includes CD34+ hematopoietic stem cell (HSC) and mescenchymal stem cell (MSC) (Brenner et al. 2004 in bone marrow;Wynn et al. 2004;Honczarenko et al. 2006;Cheng et al. 2008).Owing to these cells are necessary for vascularization and osteanagenesis, it is presumed that the SDF-1 being incorporated in 3D support is not Only supplement local cell but also supplement hematopoietic stem cell and MSC.
In addition to SDF1, support also delivers BMP-7.Owing to mesenchymal cell is being converted in osteoblast by BMP-7 Play central role, thus it is speculated that the dystopy observed in our the most celliferous support or original position mineralising are by being supplemented by SDF1 Stem cell/progenitor cell BMP-7-mediation osteogenic differentiation and realize.But, result shows, containing SDF1 and In the support of BMP-7, at two transplantation sites, there is little and inconsistent mineralising evidence.Suboptimum osteogenesis be probably by In the quick release of BMP-7, because collagen protein fast degradation in vivo.
It is interesting that compared with back, observe less mineralised zones in extracting groove transplantation site, although blood and Medullary cell enriches.This is likely due to removing the healing extracting groove after lower jaw central incisor and be likely to be due to the transplanting of support And postpone.The lip wall that the surgical operation persistent period extended can also result in sensitive paper the thinnest is easier to postoperative re-absorption.Due to tooth Tooth and surrounding tissue are the most extremely brittle weak, it is known that the hurtless measure of Rat Mandibular front tooth extracts the great technical difficulty of program.Under little rat The process of jaw also makes this program the most complicated.
In this study, Histological evaluation confirms that many grooves have lost their lipstick plate.This is likely due to remaining Lip wall is very thin.During lip re-absorption and this process of reinventing with time slot, we improve the possibility that may increase broken bone active Property.The agglutination that previous built vertical rat molar extracts groove is divided into three phases: commitment (1-5 days), period clot Organize and groove has been covered by epithelium part;The bone formation stage (5-20 days);With bone remodeling stage (20-60 days), now children Osseous maturation and alveolar ridge reinvent (Pietrokovski 1967).Histomorphometric shows, due to after extracting at most 112 days, height and width all reduced, and anodontia lower jaw experiences significant size and reduces (Elsubeihi 2004).Consider to gather journey The fact that sequence is carried out after the transfer on the 9th week, may reinvent and shrink the actively generation when gathering.
Generally speaking, this discovery proves in live body rat model, born cell migration can be induced to enter and have blood simultaneously Pipe generates and in angiopoietic PCL-HA support.This research is emphasized, compared with in the support of matched group, with SDF1 and In the PCL-HA support of BMP-7 dipping, Premeabilisation of cells and angiogenesis increase.Verified, compared with position, subcutaneous back, pulling out Go out the degree of cell ingrowth and angiogenesis in groove location bigger.These find to confirm in extracting groove location with SDF1 and The support of BMP-7 dipping will present the hypothesis of maximum proliferation potential.Therefore, pulled out in the presence of SDF1 and BMP-7 by proof Go out cell and the vessel density of the enrichment observed in groove, it is shown that diving of the tooth in-situ regeneration of use cell playback technology Energy.
Embodiment 2: by the regeneration of chemotaxis;Supplementing of the PDGF induction of alveolus stem cell/progenitor cell
Stem cell/progenitor cell separates from numerous tissues.Known bone marrow is the rich sources of stem cell/progenitor cell One of, including both hematopoietic stem cell (HSC) and mescenchymal stem cell/stromal cell (MSC).Although fibroblast sample MSC First find in the bone marrow of long bone in nineteen seventies, but found that the bone marrow of face alveolar bone contained with long later The cell that bone MSC is similar, but it is likely to be of the bigger effect towards the differentiation of at least osteogenic.Due to alveolus MSC derived from Neural crest/mesenchymal cell, in embryo's origin, the attached MSC from mesoderm-derivative is different, and MSC is passed through in the present embodiment research Chemotaxis make the new ant algorithms of tissue regeneration.Dental pulp is the unique soft tissue of tooth and keeps tooth as organ Dynamic equilibrium.Root canal is one of modal dental procedure, wherein eradicates pulp tissue alive, and by the heat of biologically inert Plastic material replaces.Tooth after root pipe is deprived of viability biology, thus, it is easy to infect, fracture and damage.Due to tooth Marrow is connected with alveolus bone marrow, and inventor thinks can supplement alveolus MSC so that pulp tissue regenerates.
The multiple healthy patients extracted by the tooth for medical science needs obtain little alveolar bone sample.Monokaryon and attachment Slight culture-the expansion of cell.First sieved the MSC (p3) passed through in early days by immunocytochemistry and flow cytometry, send out Now express Stro-1, CD 105, CD73, CD44 and CD90, but do not express CD34.Alveolus MSC is the most chemically defined Jie In matter differentiation become osteogenic, become fatty, become cartilage with become flesh sexual cell.At multiple cytokines and the shadow of somatomedin Under sound, transwell insertion system is studied the migration of alveolus MSC.
When multiple time points describe cell migration in detail, the PDGF β β of 50ng/ml is the most significant.Confirm expression of receptor.
These find the stem cell/progenitor cell benefit towards tissue regeneration of explanation inducing endogenous and/or transplanting together Fill.
List of references
Alberektsson T and Johansson C 2001 Osteoinduction, osteoconduction and Osseointegration. (self-bone grafting, bone conduction and Integrated implant) Eur.Spine J.10 Suppl.2 S96-101.
Alhadlaq, A. and Mao, J (2004)." Mesenchymal stem cells:isolationand Therapeutics. (mescenchymal stem cell: separate and treat) " Stem Cells Dev 13 (4): 436-48.
Alhadlaq, A. and Mao, J (2005).“Tissue-engineered osteochondralconstructs In the shape of an articular condyle. (the bone cartilage structure of the tissue-through engineering approaches of condyle joint shape) " J Bone Joint Surg Am 87 (5): 936-44.
Alhadlaq, A. and Mao, J (2004).“Adult stem cell driven genesis ofhuman- Shaped articular condyle. (adult stem cell in humanoid condyle joint drives and generates) " Ann Biomed Eng 32 (7): 911-23.
Astrand P, Carlsson G, Changes in the alveolar process afterextractions In the white rat.A histologic and fluorescence microscopicstudy. (is pulling out in white mouse Go out the change that rear alveolus processes. histology and fluorescence microscope studies) Acta Odontol.Scand.27 1 (1969), 113- Page 127.
Alpaslan C, Irie K, Takahashi K, Ohashi N, Sakai H, Nakajima T, Ozawa H (1996)Long-term evaluation of recombinant human bonemorphogenetic protein-2 Induced bone formation with a biologic andsynthetic delivery system. (uses biology Learn and the bone formation of synthesis delivery system long-term assessment recombinant human bone morphogenesis protein-2 induction) Br J of Oral Maxillofac Surg 34,414-418.
Amar S, Han X.The impact of periodontal infection on systemicdiseases. (periodontal infection impact on systemic disease) Med Sci Monit 2003;9:RA291-RA299.
Amar S.Implications of cellular and molecular biology advances Inperiodontal regeneration. (impact in periodontal regenerative of the Cytobiology and molecular biology progress) Anat Rec 1996:245:361-373.
Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M and Miyazono K 2001 Synergistic effects of different bone morphogeneticprotein type I receptors (alkali phosphatase is lured on alkaline phosphatase induction. by different bone morphogenetic protein I receptors The cooperative effect led) J.Cell.Sci.1141483-9.
Aono A, Hazama M, Notoya K, Taketomi S, Yamasaki H, TsukudaR, Sasaki S and Fujisawa Y 1995 Potent ectopic bone-inducing activity ofbone morphogenetic Protein-4/7 heterodimer. (the effective dystopy bone-induced activity of BMP-4/7 heterodimer) Biochem.Biophys.Res.Commun.210670-7。
Arceo N, Saulk JJ, Moehring J, Foster RA, Somerman MJ.Human periodontal Cells initiate mineral like nodules in vitro. (people's periodontal cell external initiation mineral sample tuberosity) J Periodontol 1991:62:499-503.
Artico M, Ferrante L, Pastore F S, Ramundo E O, Cantarelli D, Scopelliti D With Iannetti G 2003 Bone autografting of the calvaria andcraniofacial skeleton: Historical background, surgical results in a series of15 patients, and review Of the literature. (the bone autotransplantation of braincap and craniofacial skeleton: historical background, the surgery hands of a series of 15 patients Art result and literature review) Surg.Neurol 60 71-9.
Arzate H, Chimal-Monroy J, Hernandez-Iagunas L, Diaz de Leon L.Human cementum protein extract promotes chondrogenesis andmineralization in Mesenchymal cells. (human cementum protein extract promotes Subchondral drilling and mineralising in mesenchymal cell) J Periodontal Res 1996:31:144-148.
Arzate H, Olsen SW, Page RC, Goan AM, Narayanan AS.Production of a Monoclonal antibody to an attachment protein derivedfrom human cementum. (to by The accessory protein generation monoclonal antibody that human cementum is derivative) FASEB J 1992:6:2990-2996.
Ashman A, LoPinto J, Rosenlicht J.Ridge augmentation forimmediate Postextraction implants:eight year retrospective study. (extracts rear graft for immediately Ridge strengthen: retrospective research in 8 years) Pract Periodontics AesthetDent 1995:7:85-94.
Astrand P, Carlsson G, Changes in the alveolar process afterextractions In the white rat.A histologic and fluorescence microscopicstudy. (is pulling out in white mouse Go out the change that rear alveolus processes. histology and fluorescence microscope studies) Acta Odontol.Scand.271 (1969), 113- Page 127.
Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB.Tissueengineered autologous Bladders for patients needing cystoplasty. (needs patient engineered of cystoplasty Autologous bladder) Lancet 2006;367:1241-6.
Balic A, Mina M.Analysis of developmental potentials of dentalpulp in Vitro using GFP transgenes. (using the dental pulp ectogenesis Potentials of GFP transgenic) Orthod Craniofac Res 2005:8:252-258.
Bartold PM, McCulloch CA, Narayanan AS, Pitaru S.Tissueengineering:a new Paradigm for periodontal regeneration based onmolecular and cell biology. (group Weaver's journey: the new example of periodontal regenerative based on molecule and cytobiology) Periodontol 20002000:24:253-269.
Bartold PM, Narayanan AS.Molecular and cell biology of healthyand Diseased periodontal tissues. (molecule of healthy and ill periodontal tissue and cytobiology) Periodontol 20002006:40:29-49.
Bartold PM, Narayanan AS.Periodontal regeneration.In:Biology ofthe (periodontal connects tissue biological and learns periodontal connective tissues, Chapter 11., the periodontal in Chapter 11 Regeneration) Chicago:Quintessence Publishing, 1998.
Bax BE, Wozney JM, Ashhurst DE (1999) Bone morphogeneticprotein- 2increases the rate of callus formation after fracture of the rabbittibia. (bone The speed of callus formation after morphogenesis protein-2 raising rabbit fracture of tibia) CalcifTissue Int 65,83-89.
Becker W, Becker BE.Periodontal regeneration:a contemporaryevaluation. (periodontal regenerative: Modern Assessment) Periodontol 2000 1999:19:104-114.
Berkovitz BKB, Holland GR, Moxham BJ. is at Berkovitz BKB, Holland GR, Moxham The Color Atlas and Textbook of OralAnatomy that BJ edits, Histology and Embryology. (mouth Anatomical cavity, Histology and Embryology coloured picture and textbook) in Microscopic anatomy of oro-dental Tissues. (microscopic anatomy of oral cavity tissue) London: Mosby-Wolfe, 1992;109-228.
Berry JE, Zhao M, Jin Q, Foster BL, Viswanathan H, SomermanMJ.Exploring The origins of cementoblasts and their trigger factors. (origin of cementoblast and The research of their the triggering factor) Connect Tissue Res 2003:44. (Suppl.1): 97-102.
Bleul et al. A highly efficacious lymphocyte chemoattractant, stromal Cell-derived factor l (SDF-1) (efficient lymphocyte chemoattractant, the factor 1 (SDF-of stromal cell-derivative 1)) J.Exp.Med.184:1101-1109,1996.
Bohl KS, Shon J, Rutherford B, Mooney DJ.Role of syntheticextracellular Matrix in development of engineered dental pulp. (send out at through engineering approaches dental pulp by synthetic cell epimatrix Effect in educating) Biomater Sci Polymer Ed 1998:9:749-764.
Bosshardt DD, Zalzal S, McKee MD, Nanci A.Developmentalappearance and distribution of bone sialoprotein and osteopontin in humanand rat cementum. (bone salivary gland albumen and the growth outward appearance of osteopontin and distribution in people and rat cementum) Anat Rec 1988:250:13- 33。
Bosshardt DD.Are cementoblasts a subpopulation of osteoblasts or aunique phenotype?(cementoblast is osteoblastic subgroup or unique phenotype?) JDent Res 2005:84: 390-406。
Boyne P J 2001 Application of bone morphogenetic proteins in Thetreatment of clinical oral and maxillofacial osseous defects. (Bones morphology generation egg Application in processing Clinical mouth and upper jaw facial bone defect in vain) J.Bone Joint Surg.Am.83A S 146-50.
Braut A, Kollar EJ, Mina M.Analysis of the odontogenic andosteogenic Potentials of dental pulp in vivo using a collal-2.3-GFPtransgene. (uses Odontogenic and the analysis of osteogenic potential in the dental pulp body of collal-2.3-GFP transgenic) Int J Dev Biol 2003: 47:281-292.
Brown A, Stock G, Patel A A, Okafor C and Vaccaro A 2006Osteogenic protein- 1:a review of its utility in spinal applications. (osteogenic albumen-1: it is in spinal column is applied The summary of effectiveness) Biodrugs 20243-51.
Burns JS, Abdallah BM, Guldberg P, Rygaard J, Schroder HD, Kassem M.Tumorigenic heterogeneity in cancer stem cells evolved fromlong-term Cultures of telomeraseimmortalized human mesenchymal stemcells. is (by telomerase immortality Change cancer stem cell carcinogenic different that the extended culture of (telomeraseimmortalized) human mesenchymal stem cell develops Matter) Cancer Res 2005:65:3126-3135.
Carlisle E and Fischgrund J S 2005 Bone morphogenetic proteins forspinal Fusion. the Spine J.55 240-9 (for the bone morphogenetic protein of spinal fusion).
Carlson NE, Roach RB.Platelet-rich plasma:clinical applications Indentistry. the J Am DentAssoc 2002:133 (rich in hematoblastic blood plasma: the clinical practice in odontology): 1383-1386。
Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, Chiarieri D, McKenzie S, Broxmeyer HE, Moore MA.Characterizationof human bone marrow Fibroblast colonyforming cells (CFU-F) and theirprogeny. (people's marrow fibroblast colony shape Become cell (CFU-F) and the characteristic of their offspring) Blood 1980:56:289-301.
Castro-Malaspina H, Rabellino EM, Yen A, Nachman RL, Moore MA.Human (bone marrow becomes megakaryocyte stimulation of proliferation of bonemarrow fibroblasts. People's megalokaryocyte of fibrocellular propagation stimulates) Blood1981:57:781-787.
Causa F, Netti A, Ambrosio G, Ciapetti G, Baldini N, PaganiS, Martini D, Giunti A.Poly-ε-caprolactone/hydroxyapatite compositesfor bone regeneration: In vitro characterization and human osteoblastresponse. (for osteanagenesis poly-ε-oneself in Ester/hydroxylapatite compound: vitro characterization and human osteoblast cell's response), 2005, Journal of Biomedical Materials Research Part A76A (1): 151-162.
Chai Y, Jiang X, Ito Y et al. Fate of the mammalian cranial neuralcrest During tooth and mandibular morphogenesis. (during tooth and lower jaw form occur mammal cranium The destiny of neural crest) Development 2000;127:1671-9.
Chai Y, Slavkin HC.Prospects for tooth regeneration in the 21stcentury:a perspective. (21 century regeneration of tooth prospect: distant view) Microsc Res Tech2003;60: 469-79。
Chen D, HarrisMA, Rossini G, Dunstan C R, Dallas S L, FengJ Q, Mundy G R and Harris S E 1997 Bone morphogenetic protein2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation markergene expression during the induction of mineralized bone matrixformation in cultures of fetal rat calvarial Osteoblasts (in the osteoblastic culture of Fetal rat braincap, during the bone matrix of induction mineralising is formed, bone shape State generation albumen 2 (BMP-2) strengthens BMP-3, BMP-4 and bone cell differentiation marker gene is expressed) CalcifTissue Int.60283-90。
Chen D, Zhao M, Mundy GR (in December, 2004), Bone morphogeneticproteins (Bones morphology There is albumen), Growth Factors 22 (4): 233-4.
Cheng, H., Jiang, W., Phillips, F.M., Haydon, R.C., Peng, Y., Zhou, L., Luu, H.H., An, N., Breyer, B., Vanichakarn, P., Szatkowski, J.P., Park, J.Y. and He, T.C.Osteogenic activity of the fourteentypes of human bone morphogenetic proteins(BMPs).(14 Plant the osteoblastic activity of human bone morphogenesis protein (BMP)) J.Bone.Joint.Surg.Am.85A, 1544,2003.
Chim, H. and Schantz, J.T.Human circulating peripheral bloodmononuclear (people for cranium organizational project circulates peripheral blood to cells for calvarial bone tissue engineering. Liquid mononuclear cell) Plast.Reconstr.Surg.116,1726,2006.
Chim, H., Hutmacher, D.W., Chou, A.M., Oliveira, A.L., Reis, R.L., Lim, T.C. and Schantz, J.T.A comparative analysis of scaffoldmaterial modifications for Load-bearing applications in bone tissueengineering. (should for carrying in bone tissue engineer The modified comparative analysis of timbering material) Int.J.Oral Maxillofac.Surg.35,923,2006.
Chim, H., Ong, J.L., Schantz, J.T., Hutmacher, D.W. and Agrawal, CM.Efficacy of glow discharge gas plasma treatment as a surfacemodification process for (glow discharge gas plasmas processes as using three-dimensional poly (D/L-lactide) scaffolds. Effect of surface modification in three-dimensional poly-(D/L-lactide) support) J.Biomed.Mater.Res.65,327,2003.
Cho MI, Matsuda N, Lin WL, Moshier A, Ramakrishnan PR.Invitro formation Of mineralized nodules by periodontalligament cells fromthe rat. is (by from rat Periodontal Ligament Cells external formation Mineral nodules) CalcifTissue Int 1992:50:459-467.
Choi RS, Riegler M, Pothoulakis C, Kim BS, Mooney D, VacantiM, Vacanti JP.Studies Studies of brush border enzymes, basementmembrane components, and The electrophysiology of tissue-ehgineeredneointestine. (brush border of the new intestinal of tissue-through engineering approaches Enzyme, basement membrane composition and electrophysiological research), J.ofPed.Surg.33 (7): 991-996.
Chopp M, Zhang XH, Li Y, Wang L, Chen J, Lu D, Lu M, Rosenblum M.Spinal cord Injury in rat:treatment with bone marrowstromal cell transplantation. be (rat Spinal cord injuries receptor: use marrow stromal cell transplantation) Neuroreport 2000:11:3001-3005.
Claveau I, Mostefaoui Y and Rouabhia M 2004 Basement membfaneprotein and matrix metalloproteinase deregulation in engineered humanoral mucosa Following infection with Candida albicans. is (by human mouth in through engineering approaches after candida albicans infection Basement membrane proteins in mucosa and matrix metalloproteinase counter regulation) Matrix Biol.23477-86.
Crane, G.M., Ishaug, S.L. and Mikos, A.G.Bone tissueengineering. (bone tissue engineer) Nat.Med.12,1322,1995.
D ' Errico JA, Ouyang H, Berry JE, MacNeil RL, Strayhorn C, Imperiale MJ, Harris NL, Goldberg H, Somerman MJ.Immortalizedcementoblasts and periodontal Ligament cells in culture. (immortalization cementoblast and Periodontal Ligament Cells in culture) Bone1999:25:39-47.
Deans RJ, Moseley AB.Mesenchymal stem cells:biology andpotential Clinical uses. (mescenchymal stem cell: biology and potential clinical practice) ExpHematol 2000:28:875- 884。
Denizot F and Lang R 1986 Rapid colorimetric assay for cell growthand survival.Modifications to the tetrazolium dye procedure givingimproved Sensitivity and reliability. (for cell growth and the rapid colorimetric determination of existence. to tetrazolium dyeing procedure Amendment produce improve sensitivity and reliability) J.Immunol.Methods 89 271-7.
Desbois C and Karsenty G 1995 Osteocalcin cluster:implications Forfunctional studies. (Bone Gla protein bunch: the hint of functional study) J.Cell.Biochem.57379-83.
De Wynter EA, Emmerson AJ, Testa NG.Properties of peripheralblood and Cord blood stem cells. (peripheral blood and the character of cord blood stem cell) Baillieres Best Pract Res Clin Haematol 1999:12:1-17.
Dua HS, Azuara-Blanco A.Limbal stem cells of the cornealepithelium. (angle The limbal stem cell of film epithelium) Surv Ophthalmol 2000:44:415-425.
Duailibi et al. Long-term case history reports. (long-term behavior historical report) JOral Implantol 2000:26:276-290.
Duailibi MT, Duailibi SE, Young CS, Bartlett JD, Vacanti JP, Yelick PC.Bioengineered teeth from cultured rat tooth bud cells. is (from the rat tooth bud cultivated The Bioengineered tooth of cell) J Dent Res 2004:83:523-528.
Duailibi SE, Duailibi MT, Vacanti JP, Yelick PC.Prospects for Toothregeneration. (prospect of regeneration of tooth) Periodontology 2000.2006;41:177-87.
Elsubeihi E, Heersche J, Quantitative assessment of post- extractionhealing and alveolar ridge remodelling of the mandible in female Rats. (quantitative assessment that after the extracting of female rats lower jaw, healing and alveolar ridge are reinvented), Archives of OralBiology 2004,49:5, the 401-412 page.
Eppley B L, Pietrzak W S and Blanton M W 2005Allograft andalloplastic Bone substitutes:a review of science and technology for Thecraniomaxillofacial surgeon. (allograft and alloplasm bone substitute: craniomaxillofacial surgery doctor's Science and technology is summarized) J.Craniofac.Surg.16 981-9.
Fenton AH, Zarb GA, MacKay HF.Overdenture oversights. (overlay denture supervision) Dent Clin North Am 1979:23:117-130.
Fibbe, W.E., Pruijt, J.F., van Kooyk, Y., Figdor, C.G., Opdenakker, G. and Wille, R.The role of metalloproteinases andadhesion molecules in interlukin-8- Induced stem cell mobilization. (do carefully what interlukin-8-induced by metalloproteases and adhesion molecule Born of the same parents move in effect) Semin.Hematol.37,19,2000.
Fiedler, J., Leucht, F., Waltenberger, J., Dehio, C and Brenner, R.E.VEGF-A and PlGF-1 stimulate chemotactic migration of humanmesenchymal progenitor cells. (chemotactic migration of VEGF-A and PlGF-1 stimulation human mesenchyme's progenitor cell) Biochem.Biophys.Res.Commun.334,561,2005.
Fong HK, Foster BL, Popowics TE, Somerman MJ.Thecrowning achievement: Getting to the root of the problem. (crowning is achieved: arrive the root of problem) J Dent Educ 2005;69:555-70.
Friedenstein AJ, Ivanov-Smolenski AA, Chajlakjan RK, GorskayaUF, Kuralesova AI, Latzinik NW, Geraswimow UW.Origin of bonemarrow stromal Mechanocytes in radiochimeras and heterotopictransplants. is (in radiation chimera and dystopy The fibroblastic origin of bone marrow matrix in graft) Exp Hematol 1978:6:440-444.
(fibroblastic precursor is thin for Friedenstein AJ.Precursor cells of mechanocytes. Born of the same parents) Int Rev Cytol 1976:47:327-359.
Fuchs JR, Hannouche D, Terada S, Vacanti JP, Fauza DO.Fetaltracheal augmentation with cartilage engineered from bonemarrow-derived mesenchymal Progenitor cells. (fetal tracheal using the cartilage by the mesenchyme progenitor cell through engineering approaches of bone marrow-derivative is strengthened) J Pediatr Surg 2003:38:984-987.
Fujiwara N, Tabata MJ, Endoh M, Ishizeki K, Nawa T.Insulin-iikegrowth factor-1 stimulates cell proliferation in the outer layer of Hertwig′ sepithelial root sheath and elongation of the tooth root in mouse molars Invitro. (cell proliferation in the outer layer of insulin-like growth factor-i stimulated in vitro Hertwig epithelial root sheath and mice mortar The elongation of the root of the tooth in tooth) Cell Tissue Res 2005;320:69-75.
Gazdag AR, Lane JM, Glaser D.Alternatives to autogenous bonegraft: Efficacy and indication. (substitute of spontaneous bone graft: effect and instruction) JAm Acad Orthop Surg 1995;3:1-8.
Gazzerro E, Rydziel S and Canalis E 1999 Skeletal bonemorphogenetic Proteins suppress the expression of collagenase-3 by ratosteoblasts. (skeletal bones shape The suppression Collagenase-3 expression by rat osteoblast of state generation albumen) Endocrinology 140 562-7.
Geiger M, Li R H and Friess W 2003 Collagen sponges for boneregeneration With rhBMP-2. (using rhBMP-2 for the collagen protein sponge of osteanagenesis) Adv.Drug Deliv.Rev.55 1613- 29。
Giannobile WV, Lee CS, Tomala MP, Tejeda KM, Zhu Z.Platelet-derived growth factor(PDGF)gene delivery for application inperiodontal tissue Engineering. the J (for somatomedin (PDGF) gene delivery of platelet-derivative of periodontal tissue engineering) Periodontol 2001:72:815-823.
Giannobile WV.Periodontaltissue engineering by growth factors. is (by life The periodontal tissue engineering of the long factor) Bonel996:19:23S-37S.
Giannoudis P V and Tzioupis C 2005 Clinical applications of BMP-7:the UK Perspective. (clinical practice of BMP-7: UK distant view) Injury 36 Suppl.3S47-50.
Giannoudis P V, Dinopoulos H and Tsiridis E 2005 Bone substitutes:an Update. (bone substitute: up-to-date information) Injury 36 Suppl.3 S20-7.
Gojo S, Gojo N, Takeda Y, Mori T, Abe H, Kyo S, Hata J, Umezawa A.In vivo cardiovasculogenesis by direct injection of isolatedadult mesenchymal stem Cells. the Exp Cell Res 2003 (by the internal cardiovascular generation of the adult mesenchymal stem cells that direct injection separates): 288:51-59.
Griffith, L.G. and Naughton, G.Tissue engineering-currentchallenges and Expanding opportunities. (organizational project-existing challenge and dilator meeting) Scienee 295,1009,2002.
Groeneveld E H and Burger E H 2000Bone morphogenetic proteins inhuman Bone regeneration. (bone morphogenetic protein in people's osteanagenesis) Eur.J.Endocrinol.1429-21.
Gronthos S, Chen S, Wang CY, Robey PG, Shi S.Telomeraseaccelerates Osteogenesis of bone marrow stromal stem cells byupregulation of CBFAl, (by raising CBFAl, osterix and Bone Gla protein, it is thin that telomerase accelerates marrow mesenchymal stem to osterix, and osteocalcin. The osteogenesis of born of the same parents) J Bone MinerRes 2003:18:716-722.
Gronthos S, Graves SE, Ohta S, Simmons PJ.The STRO-1+fraction of adult Human bone marrow contains the osteogenicprecursors. (the STRO-1+ fraction of adult people's bone marrow Containing osteogenic precursor) Blood1994:84:4164-4173.
Gronthos S, Mankani M, Brahim J, Gehron Robey P, Shi S.Postnatal human (people's dental pulp day after tomorrow of in vitro and in vivo is dry thin for dental pulp stem cells (DPSC) in vitro and in vivo. Born of the same parents (DPSC)) Proc Natl Acad Sci USA 2000:97:13625-13630.
Gronthos S, Zannettino AC, Graves SE, Ohta S, Hay SJ, SimmonsPJ.Differential cell surface expression of the STRO-1 and alkalinephosphatase antigens on discrete developmental stages in primary (STRO-1 and alkaline phosphatase antigen are in the Primary cultures of people's osteocyte for culturesof human bone cells. The differentiation cell surface expression of discontinuous stage of development) J Bone Miner Res1999:14:47-56.
Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kaortesidis A, S immons PJ.Molecular and cellular characterization ofhighly purified stromal The stem cells derived from human bone marrow. (molecule by high-purity stroma stem cell of people's bone marrow derived And cell characterization) J cell Sci 2003:116:1827-1835.
Guglielmotti M, Cabrini R, Alveolar wound healing and ridgeremodeling After tooth extraction in the rat:a histologic, radiographic, andhistometric Study. (alveolus wound healing and ridge after tooth is extracted in rats are reinvented: histology, radiophotography and Histological research) J.Oral Maxillofac.Surg.435 (1985), the 359-364 page.
Harada H, Mitsuyasu T, Toyono T, Toyoshima K.Epithelial stemcells in Teeth. (epithelial stem cell in tooth) Odontology 2002;90:1-6.
Harada H, Ohshima H.New perspectives on tooth development andthe Dental stem cell niche. (tooth development and the new distant view of tooth steam cell microhabitat) Arch Histol Cytol 2004:67:1-11.
Hawkins N, Garriga G.Asymmetric cell division:from a toz. (asymmetric cell Division: from toz) Genes Dev1998:12:3625-3638.
Heijl L, Heden G,G,A.Enamel matrixderivative (EMDOGAIN) the m the treatment of intrabony periodontalpockets. (treatment of periodontal pocket in bone In enamel matrix derivative (EMDOGAIN)) JClin Periodontol 1997:24:705-714.
Heo SJ, Kim S E.Fabrication of porous scaffolds for bone Tissueengineering using a 3-D robotic system:Comparison with Conventionalscaffolds fabricated by particulate leaching. (uses 3-D robot system system Make the porous support for bone tissue engineer: with the comparison being leached the conventional bracket manufactured by granule) Mol Cell Biol 2007;3:179-180.
Herodin, F., Bourin, P., Mayol, J.F., Lataillade, J.J. and Drouet, M.Short-term injection of antiapoptotic cytokine combinations soon afterlethal gamma- (after lethal γ-radiation, short-term injects anti-apoptotic cytokine group to irradiation promotes survival. immediately Compound promotes existence) Blood.101:2609-2616.
Hirooka H.The biologic concept for the use of enamel matrix protein: True periodontal regeneration. (biological concept of use enamel stromatin: real periodontal regenerative) Quintessence Int 1998:9:621-630.
Hogan B L 1996 Bone morphogenetic proteins:multifunctionalregulators Of vertebrate development. (bone morphogenetic protein: the multifunctional regulator of vertebrate animal development) Genes Dev.101580-94。
Hollinger J O, Uludag J O and Winn S R 1998 Sustained releaseemphasizing Recombinant human bone morphogenetic protein-2. (recombinant human bone morphogenesis protein-2 emphatically Slow release) Adv.Drug Deliv.Rev.31 303-18.
Honda MJ, Sumita Y, Kagami H, Ueda M.Histological andimmunohistochemical Studies of tissue engineered odontogenesis. (engineered odontogenetic histology and immune group Weave chemistry is studied) Arch Histol Cytol 2005:68:89-101.
Horwitz EM, Gorden PL, Koo WK, Marx JC, Neel MD, McNallRY et al. Isolated allogenic bone marrow-derived messenchymal cellsengraft and stimulate growth In children with osteogenesis imperfect:implications for cell therapy of Bone. (mesenchymal stem cells transplantation of the allogeneic bone marrow of separation-derivative and stimulate the growth suffering from the most full child of osteogenesis: The hint of the cell therapy of bone) Proc Natl Acad Sci USA 2002;99;8932-7.
Horwitz EM, Prockop DJ, Gordon PL, Fitzpatrick LA, Neel MD, McCarville ME Et al. Clinical responses to bone marrow transplantationin children with severe Osteogenesis imperfect. (clinical response to suffering from the most full bone in children implantation of marrow of serious osteogenesis) Blood 2001;97:1227-31.
Howell TH, Fiorellini JP, Paquette DW, Offenbacher S, GiannobileWV, Lynch SE, A phase I/II clinical trial to evaluate a combination ofrecombinant human plateletderived gfowth factor-BB and recombinantinsulin-like growth factor in Patients with periodontal disease. (evaluates the derivative PDGF-BB of recombinant human blood platelets and restructuring The combination of body insulin like growth factor I/II clinical trial phase in the patient suffering from periodontal disease) J Periodontol1997:68:1186-1193.
Hu B, Nadiri A, Bopp-Kuchler S, Perrin-Schmitt F, Lesot H.Dentalepithelial histomorphogenesis in vitro. (generation of external tooth epithelial tissue form) JDent Res 2005;84:521-5.
Hu B, Nadiri A, Kuchler-Bopp S, Perrin-Schmitt F, Peters H, LesotH.Tissue Engineering of tooth crown, root, and periodontium. (the tissue work of corona, root and periodontal tissue Journey) Tissue Eng 2006;12:2069-75.
Hu B, Unda F, Bopp-Kuchler S et al. Bone marrow cells can giverise to Ameloblast-like cells. (medullary cell can produce ameloblast like cell) J DentRes 2006;85:416-21.
Hutmacher DW, Goh JCH, Tech SH.An introduction tobiodegradable Materials for tissue engineering applications. (for organizational project application biodegradable The introduction of material) Ann Acad Med Singapore 2001:30:183-191.
Hutmacher DW, Schantz JT, Zein I, Ng KW, Tan KC, Teoh SHMechanical Properties and Cell Cultural Response of PolycaprolactoneScaffolds Designed And Fabricated via Fused Deposition Modeling. is (by fused deposition modeled design and manufacture The engineering properties of polycaprolactone support and cell cultivate response) J Biomed Mat Res 2001,55:203-216.
Huysseune A, Van der heyden C, Sire JY.Early development ofthe Zebrafrish (Danio rerio) pharyngeal dentition (Teleostei, Cyprinidae). (Brachydanio rerio The early development of (Danio rerio) pharyngeal denture (Teleostei, Cyprinidae)) AnatEmbryol (Berl) 1998:198: 289-305。
The Tissue Engineering for Therapeutic Use1.Tokyo that Ikada Y. edits at Ikada Y: Elsevier, 1998;Tissue engineering research trendsat Kyoto University. in 1-14 (Tissue Engineering Study of Kyoto University).
Isobe M, Yamazaki Y, Mori M, Amagasa T (1999) Bone regenerationproduced in rat femur defects by polymer capsules containing recombinanthuman bone Morphogenetic protein-2. is (by the polymeric bladder containing recombinant human bone morphogenesis protein-2, at rat stock The osteanagenesis produced in bone defect) J Oral MaxillofacSurg 57,695-8.
Israel D I, Nove J, Kerns K M, Kaufman R J, Rosen V, Cox K A and Wozney J M 1996 Heterodimeric bone morphogenetic proteins showenhanced activity in vitro The and in vivo. activity of enhancing (the heterodimer bone morphogenetic protein show in vitro and in vivo) Growth Factors.13 291-300。
Ivanovski S, Haase HR, Bartold PM.Expression of bone matrixprotein mRNAs by primary and cloned cultures of the regenerativephenotype of human Periodontal fibroblasts. is (by primary and the culture of clone of people's periodontal fibroblastic reproducibility phenotype Express bone matrix protein mRNA) J Dent Res2001:80:1665-1671.
Jackman WR, Draper BW, Stock DW.Fgf signaling is required forzebrafrish Tooth development. (Brachydanio rerio tooth development needs Fgf signal to occur) DevBiol 2004:274:139-157.
Jemvall J, Thesleff I.Reiterative signaling and patterning (during mammalian tooth form occurs, signal repeatedly occurs duringmammalian tooth morphogenesis. And patterning) Mech Dev 2000:92:19-29.
Jin QM, Anusaksathien O, Webb SA, Printz MA, Giannobile WV.Engineering of Tooth supporting structures by delivery of PDGF genetherapy vectors. is (by delivering PDGF gene therapy vector through engineering approaches tooth supports structure) Mol Ther 2004:9:519-526.
Jin QM, Anusaksathien O, Webb SA, Rutherford RB, GiannobileWV.Gene Therapy of bone morphogenetic protein for periodontal tissueengineering. (is used for The gene therapy of the bone morphogenetic protein of periodontal tissue engineering) JPeriodontol 2003:74:202-213.
Jin QM, Zhao M, Webb SA, Berry JE, Somerman MJ, GiannobileWV.Cementum Engineering with threedimensional polymer scaffolds. (has the dentale of three-dimensional polymer support Matter engineering) J Biomed Mater Res A 2003:67:54-60.
Jorgensen C, Gordeladze J, Noel D.Tissue engineering throughautologous Mesenchymal stem cells. (by the organizational project of autologous mescenchymal stem cell) Current Opin Biotechnol 2004:15:406-410.
Kaigler D, Mooney DJ.Tissue engineering impact on dentistry. is (to odontology Organizational project impact) J Dent Educ 2001:65:456-462.
Kang Q et al. 2004 Characterization of the distinct orthotopicbone- forming activity of 14 BMPs using recombinant adenoirus-mediatedgene Delivery. (gene delivery of use recombinant adenovirus-mediation characterizes the different original position osteogenic activity of 14 kinds of BMP) Gene Ther.111312-20。
Karring T, Nyman S, Gottlow J, Laurell L.Development of thebiological The concept of guided tissue regenerationanimal and humanstudies. (tissue regeneration of guiding Animal and people research biology idea development) Periodontol 2000 1993:1:26-35.
Katchburian E, Arana V.Histologia e Embriologia Oral, second edition, Brazil: Editorial Medica Panamericana.Guanabara Koogan, 2005:151-179.
Kato M, Toyoda H, Namikawa T, Hoshino M, Terai H, Miyamoto S and Takaoka K 2006 Optimized use of a biodegradablepolymer as a carrier material for the Local delivery of recombinant humanbone morphogenetic protein-2 (rhBMP-2). (can Biodegradable polymer is as the carrier material of the local delivery for recombinant human bone morphogenesis protein-2 (rhBMP-2) Best use) Biomaterials 272035-41.
Kawano S, Saito M, Handa K, Morotomi T, Toyono T, Seta Y, Nakamura N, Uchida T, Toyoshima K, Ohishi M, Harada H.Characterization of dental epithelial pro Genitor cells derived fromcervical-loop epithelium in a rat lower incisor. ( By the sign of the epidermal derived tooth epithelium progenitor cell of neck-enclose in rat lower front tooth) J Dent Res 2004:83:129- 133。
Kenley R A, Yim K, Abrams J, Ron E, Turek T, Marden L J and Hollinger J O 1993 Biotechnology and bone graft substitutes. (biotechnology and bone collection succedaneum) Pharm.Res 10 1393-401。
Kim BS.Development of biocompatible synthetic extracellularmatrices For tissue engineering. (for the development of biocompatible synthetic cell epimatrix of organizational project) Trends Biotechnol 2001;16:224-230.
Kim, C.H. and Broxmeyer, H.E.In vitro behavior of hematopoieticprogenitor Cells under the influence of chemoattractants:stromalcell-derived factor-1, (under the influence of following chemoattractant, hemopoietic is remote for steel factor, and the bone marrow environment. The external behavior of CFU-GM: the factor-1 of stromal cell-derivative, the steel factor, and bone marrow environment) Blood 91,100,1998.
Kim HW, Jonathan C.Hydroxyapatite/PCL composite coatings Onhydroxyapatite porous bone scaffold for drug delivery. (the hydroxyl phosphorus delivered for medicine Hydroxyapatite on lime stone porous bone scaffold/PCL composite coating) Biomaterials2004;25:1279-1287.
Kim J, Amar S.Periodontal disease and systemic conditions: Abidirectional relationship. (periodontal disease and the whole body patient's condition: two way relation) Odontology2006;94:10- 21。
Kim SS, Utsunomiya H, Koski JA, Wu BM, Cima MJ, Sohn J, Mukai K, Griffith LG, Vacanti JP.Survival and function of hepatocyteson a novel three dimensional synthetic biodegradable polymer scaffoldwith an ihtrinsic network Ofchannels. (hepatocyte is on the polymer support of the novel three-dimensional synthesizing biological degradable containing intrinsic channel network Existence and function) Ann Surg1998:28:8-13.
Kim SS, Vacanti JP.The current status of tissue engineering Aspotential therapy. (organizational project is as the present situation of potential treatment) Semin Pediatr Surg1999:8:119- 123。
Koempel JA, Patt BS, O ' Grady K, Wozney J, Toriumi DM (1998) The effect of recombinant human bone morphogenetic protein-2 on theintegration of porous (porous hydroxyapatite is moved hydroxyapatite implants with bone. by recombinant human bone morphogenesis protein-2 The impact of the integration of plant and bone) J BiomedMater Res 41,359-363.
Koh YH, Jun IK, Kim HE.Fabrication of poly ε-caprolactone/ Hydroxyapatite scaffold using rapid direct deposition. (uses quick Direct precipitation to manufacture Poly-epsilon-caprolactone/hydroxyapatite scaffold) Materials Letters volume 2006: the 60: 9-10 phase: 1184-1187.
Kollet, O., Shivtiel, S., Chen, Y.Q., Suriawinata, J., Thung, S.N., Dabeva, M.D., Kahn, J., Spiegel, A., Dar, A., Samira, S., Goichberg, P., Kalinkovich, A., Arenzana-Seisdedos, F., Nagler, A., Hardan, I., Revel, M., Shafritz, D.A. and Lapidot, T.HGF, SDF-1 and MMP-9 areinvolved in stress-induced CD34p stem cell (HGF, SDF-1 and MMP-9 relate to stress-induction to recruitment to the liver.Stem cell is supplemented to Liver) J.Clin.Invest.112,160,2003.
Kortesidis, A., Zannettino, A., Isenmann, S., Shi, S., Lapidot, T. and Gronthos, S.Stromal-derived factor-1 promotes the growth, survival, and development of (substrate-derivative factor-1 promotes human bone marrow stroma stem cell to human bone marrow stromal stem cells. Grow, survive and grow) Blood 105,3793,2005.
Krebsbach PH, Mankani MH, Satomura K, Kuznetsov SA, RobeyPG.Repair of Craniotomy defects using bone marrow stromal cells. (uses marrow stromal cell split cranium art The reparation of defect) ransplantation 1998:66:1272-1278.
Kuboki Y, Saito T, Murata M, Takita H, Mizuno M, InoueM, Nagai N, Poole AR (1995)Two distinctive BMP-carriers inducezonal chondrogenesis and membranous Ossification, respectively;geometrical factors of matrices for cell- Differentiation. (two kinds of different BMP-carriers induce banding Subchondral drilling and periosteal ossification respectively;For cell-differentiation The geometrical factor of substrate) Connect Tissue Res 32,219-226.
Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska- Wieczorek, A., Ratajczak, J., and Ratajczak, M.Z.Traffickingof normal stem cells And metastasis of cancer stem cells involve similarmechanisms:pivotal role of (contact of normal stem cell relates to similar mechanism: SDF-1-with the transfer of cancer stem cell to the SDF-1-CXCR4 axis. The central action of CXCR4 axle) Stem Cells 23,879,2005.
LatlammeC, Mahmoud R.Effect of BMP-2 and BMP-7 homodimersand a mixture of BMP-2/BMP-7 homodimers on osteoblast adhesion andgrowth following culture On a collagen scaffold. (after collagen scaffold is cultivated, BMP-2 and BMP-7 homodimer and BMP-2/ BMP-7 homodimer mixture is on osteoblast bonding and the impact of growth), 2008 Biomed.Mater.3 015008 (page 10).
Landers, R., Pfrister, A (2005) .Rapid prototyping in medicine. (fast in medical science Speed raw basin) Internal Report, EnvisionTec, Germany.
Landers, R., U.Hubner et al. (2002). " Rapid prototyping of scaffoldsderived from thermoreversible hydrogels and tailored for applications intissue Engineering. (derived and be suitably applied the rapid prototype manufacturing of support of organizational project by the hydrogel of thermal reversion) " Biomaterials23 (23): 4437-47.
Lang H, Sch ü ler N, Nolden R.Attachment formation followingreplantation Of cultured cells into periodontal defects. is (after replanting the cell of cultivation in periodontal defects Appurtenance formed) J Dent Res 1998:77:393-405.
Langer R, Vacanti JP.Tissue engineering. (organizational project) Science1993:260:920- 926。
Lapidot, T. and Petit, I.Current understanding of stem cellmobilization: The roles of chemokines, proteolytic enzymes, adhesionmolecules, cytokines, and Stromal cells. (stem cell move work as feed-forward nets: chemotactic factor, proteolytic enzyme, bonding molecule, cytokine and base The effect of cell plastid) Exp.Hematol.30,973,2002.
Laurell L, the Gottlow J.Guided tissue regeneration update. (tissue regeneration of guiding Update) Int J Dent 1998:48:386-398.
Lekic P, McCulloch CA.Periodontal ligament cell population:thecentral Role of fibroblasts in creating a unique tissue. (Periodontal Ligament Cells group: fibroblast exists Produce the central action in unique tissue) Anat Rec 1996:245:327-341.
Leong KF.Solid freeform fabrication of three-dimensional scaffoldsfor Engineering replacement tissues and organs. (prop up by the three-dimensional replacing tissue and organ for through engineering approaches The solid free form of frame manufactures) Biomaterials 2003;24:2363-2378.
Lijun K, Yuan G, Guangyuan L.A study on the bioactivity ofchitosan/ Nano-hydroxyapatite composite scaffolds for bone tissueengineering. is (for bone group The bioactivity research of the chitosan of weaver's journey/Nano-hydroxyapatite complex support) Eur Polym J 2006;42: 3171-3179。
Lin H.The self-renewing mechanism of stem cells in the germline. (is planting The self renewal mechanism of stem cell in system) Curr Opin Cell Biol 1998:10:687-693.
Lindskog S.Formation of intermediate cementum.I.Earlymineralization Of aprismatic enamel and intermediate cementum inmonkey. (the cemental formation of intermediate .I. aprismatic enamel and intermediate mineralising of cemental early stage in monkey) J Craniofac Genet Dev Biol 1982:2:147-160.
Liu H W, Chen C H, Tsai C L and Hsiue G H 2006 Targeted deliverysystem for juxtacrine signaling growth factor based on rhBMP-2-mediatedcarrier-protein Conjugation. (carrier-Protein Conjugation based on rhBMP-2-mediation, for the targeting of the juxtacrine signal growth factor Delivery system) Bone 39 825-36.
Lu, L. and A.G.Mikos (1996). " The importance of new processingtechniques in Tissue engineering. (importance of process technology new in organizational project) " MRS Bull 21 (11): 28-32.
Lu L., Stamatas G., Mikos A, " Controlled release of transforminggrowth Factor β l from biodegradable polymer microparticles. is (micro-from biodegradable polymer The controlled release of the Diabetes complication l of grain), J.of BiomedicalMaterials Res.Part A., volume 50, 3rd phase, the 440-451 page.
Lynch SE, Genco RJ, Marx RE. edits, Tissue engineering.Applications in Maxillofacial surgery and periodontics. (organizational process. in maxillofacial surgery operation and periodontal Application), the 1st edition, Carol Stream, IL:Quintessence Publishing, 1999.
Lyons K M, Hogan B L and Robertson E J 1995 Colocalization ofBMP-7 and BMP-2 RNAs suggests that these factors cooperativelymediate tissue (the common localization of BMP-7 and BMP-2RNA shows, Mus interactions during murine development. During section grows, these factors cooperation mediating tissue interacts) Mech.Dev.5071-83.
Ma PX, Choi JW. (AQ) Biodegradable polymer scaffolds with welldefined (have good restriction interconnects can biological dropping of spherical pore network to interconnected spherical pore network. The polymer support solved) Tissue Eng 2001:7:23-33.
Malekzeh R, Hollinger JO, Buck D, Adams DF, Mcallister BS.Isolation of human osteoblast-like cells and in vitro amplification fortissue engineering. (for the separation of human osteoblast cell's like cell and the external amplification of organizational project) J Periodontol 1998:69:1256- 1262。
Mano JF, Sousa RA, Boesel LF.Bioinert biodegradable andinjectable Polymeric matrix composites for hard tissue replacement:Stateof the art and Recent developments. (the biodegradable and injectable polymeric matrices for the biologically inert that sclerous tissues replaces Complex: the situation of this area and recent development) Compos Sci Technol 2004;64:789-817.
Manolagas S C 1998 The role of IL-6 type cytokines and theirreceptors In bone. (IL-6 cytokines and the effect in bone of their receptor) Ann.NY Acad.Sci.840194-204.
Marion, N.W. and J.J.Mao (2006). " Mesenchymal stem cells andtissue Engineering. (mescenchymal stem cell and organizational project) " Methods Enzymol 420:339-61.
Mayer H, Scutt A M and Ankenbauer T 1996 Subtle differences in themitogenic effects of recombinant human bone morphogenetic proteins-2to-7 on DNA synthesis on primary bone-forming cells and identificationof BMP-2/ 4receptor. is (for main osteoblast, the mitogenesis of recombinant human bone morphogenesis protein-2 to-7 pairs of DNA synthesis The Subtle differences of effect and the qualification of BMP-2/4 receptor) Calcif.Tissue Int.58249-55.
McCulloch CA, Nemeth E, Lowenberg B, Melcher AH.Paravascular cells in endosteal spaces of alveolar bone contribute toperiodontal ligament cell Populations. (the other vascular cell in the perimyelis space of alveolar bone contributes to Periodontal Ligament Cells group) Anat Rec 1987:219:233-242.
McCulloch CA.Origins and functions of cells essential forperiodontal Repair:the role of fibroblasts in tissue homeostasis. (repairs necessary cell for periodontal Origin and function: fibroblast effect in tissue homeostasis) Oral Dis 1995:1:271-278.
McCulloch CA.Progenitor cell populations in the periodontalligament Of mice. (the progenitor cell group in the periodontal ligament of mice) Anat Rec 1985:211:258-262.
Meinel L, Fajardo R, Hofmann S, Langer R, Chen J, Snyder B, Vunjak- Novakovic G, Kaplan D.Silk implants for the healing of criticalsize bone Defects. (the silk graft for making CD bone defect heal) Bone2005:37:688-698.
Melcher AH.Cells of periodontium:their role in the healing ofwounds. (cell of periodontal tissue: they effects in wound healing) Ann R Coll SurgEngl 1985:67:130-131.
Mikos AG, Lyman MD, Freed LE, Langer R.Wetting ofpoly (L-lactic acid) and Poly (DL-lactic-co-glycolic acid) the foams for tissueculture. (poly-(L-for tissue culture Lactic acid) and the moistening of DL-LACTIC ACID-ethanol copolymer foam) Biomaterials 1993:15:55-58.
Mikos AG, Sarakinos G, Leite SM, Vacanti JP, Langer R.Laminatedthree- Dimensional biodegradable foams for use in tissue engineering. is (for organizational project The biodegradable foam of three-dimensional of stacking) Biomaterials 1993:14:323-330.
Mikos KF.Preparation and characterization of poly L-lactic acidfoam. (preparation of poly (l-lactic acid) foam and sign) Polymer 1994;35:1068-1077.
Miletich I, Sharpe PT.Neural crest contribution to mammalian Toothformation. (contribution that mammalian tooth is formed by neural crest) Birth Defects Res CEmbryo Today 2004;72:200-12.
Mina M, Braut A.New insight into progenitor/stem cells in dentalpulp Using Collal-GFP transgenes. be (progenitor cell/stem cell in the dental pulp of use Collal-GFP transgenic Neodoxy) Cells Tissues Organs 2004:176:120-133.
Miura M, Gronthos S, Zhao M, Lu B, Fisher LW, Robey PG, Shi S.SHED:stem Cells from human exfoliated deciduous teeth. (SHED: from the stem cell of the deciduous teeth that people comes off) Proc Natl Acad Sci USA 2003:100:5807-5812.
Modino SA, Sharpe PT.Tissue engineering of teeth using adultstem Cells. (organizational project of the tooth of use adult stem cell) Arch Oral Biol 2005:50:255-258.
Moioli EK, Mao JJ.Chondrogenesis of mesenchymal stem cells Bycontrolled delivery of transforming growth factor-beta3. is (raw by controlled delivery conversion The Subchondral drilling of the mescenchymal stem cell of the long factor-β 3) Conf Proc IEEE Eng MedBiol Soc.2006;1:2647- 50。
Mooney DJ, Mikos AG.Growing new organs. (growing new organ) SciAm 1999:280: 60-65。
Mooney DJ, Powell C, Piana J, Rutherford B.Engineering dentalpulp-like Tissue in vitro. (engineered in vitro dental pulp sample tissue) Biomaterials 1996:12:865-868.
Mooney DJ.Novel approach to fabrication porous sponge of polyD, L- Lactic-co-glycolic acid without the use of organic solvents. (does not use organic solvent system Make D, the novel method of the mandruka of Pfansteihl-ethanol copolymer) Biomaterials 1996;17:1417-1422.
Moradian-Oldak J.Amelogenins:assembly, processing and controlof Crystal morphology. (amelogenin: the assembling of crystal morphology, process and control) Matrix Biol 2001:20: 293-305。
Moroni L, de Wijn JR, van Blitterswijk CA.3D fiber-depositedscaffolds For tissue engineering:Influence of pores geometry andarchitecture on dynamic Mechanical properties. (the support for the 3D fiber-deposition of organizational project: hole geometry and structure are to dynamically The impact of engineering properties) Biomaterials2006;27:974-985.
Murphy W, Simmons C, Kaigler D, Mooney D, Bone Regenerationvia a Mineral Substrate and Induced Angiogenesis. (by mineral substrates and the osteanagenesis of the angiogenesis of induction), Journal of Dental Research 2004 83:204-210.
Moss ML.Studies on dentin.I.Mantle dentin. (to tooth Quality Research .I. mantle dentin) Acta Anat (Basel) 1999:87:481-507.
Moule AJ, Li H, Bartold PM.Donor variability in the proliferationof Human dental pulp fibroblasts. (the donor variability in the propagation of human dental pulp fibroblast) Aust Dent J 1995:40:110-114.
Murata M, Inoue M, Arisue M, Kuboki Y, Nagai N (1998) Carrier-dependency of cellular differentiation induced by bonemorphogenetic protein in ectopic Sites. the Int J Oral (at the carrier-dependency of the cell differentiation that ectopic sites is induced by bone morphogenetic protein) Maxillofac Surg 27,391-396.
Murphy WL, Mooney DJ.Controlled delivery of inductive proteins, plasmid DNA and cells from tissue engineering matrices. (from organizational project substrate induction albumen, Plasmid DNA and the controlled delivery of cell) J Periodontal Res1999:34:413-419.
Muschler GF, Nakamoto C, Griffith LG., Engineering principles ofclinical Cell-based tissue engineering. (engineering philosophy of organizational project based on clinical cytology) J BONE Joint Surg Am.2004 Jul;86-A (7): 1541-58.
Nakagawa T and Tagawa T 2000 Ultrastructural study of direct boneformation induced by BMPs-collagen complex implanted into an ectopicsite. (the direct osteoplastic superstructure research of the BMP-collagen protein complex induction by transplanting in ectopic sites) Oral Dis.6 172-9。
Nakahara T, Nakamura T, Kobayashi E et al. In situ tissueengineering of Periodontal tissues by seeding with periodontalligament-derived cells. is (by making By the original position organizational project of the periodontal tissue that periodontal ligament-derivative cell is inoculated) Tissue Eng 2004;10:537-44.
Nakahara T, Nakamura T, Kobayashi E et al. Novel approach toregeneration of Periodontal tissues based in situ tissue engineering:effects of controlled Release of basic fibroblast growth factor from asandwich membrane. is (based on original position group Weaver's journey makes the novel method of paradenlal tissue regeneration: from the controlled release of the Basic fibroblast growth factor of sandwich film Impact) TissueEng 2003;9:153-62.
Nakahara T.A review of new developments in tissue engineeringtherapy For periodontitis. (summary of the new development that the organizational project for periodontitis is treated) Dent Clin North Am 2006;50:265-76, ix-x.
Nakao K, Morita R, Saji Y et al. The development of abioengineered organ Germ method. (development of Bioengineered organic microbial method) Nat Meth 2007;4:227-30.
Nakashima M, Akamine A.The application of tissue engineering Toregeneration of pulp and dentin in endodontics. (makes marrow and dentine regeneration in endodontics The application of organizational project) J.Endod 2005:31:711-718.
Nakashima M, Bone morphogenetic proteins in dentin regenerationfor Potential use in endodontic therapy. (potential Bones morphology in the dentine regeneration of tooth marrow disease treatment There is albumen) Cytokine&Growth Factor volume Reviews.2005: the 16: the 3rd phase: 369-376.
Nakashima M, Iohara K, Ishikawa M, Ito M, Tomokiyo A, Tanaka T, Akamine A.Stimulation of reparative dentin formation by exvivo gene therapy using dental pulp stem cells electrotransfected withgrowtb/differentiation factor 11 (Gdf11). (dental pulp stem cell using grown/differentiation 11 (Gdf11) electrotransfection is come by vitro gene therapy Prosthetic dentine is stimulated to be formed) Hum Gene Ther 2004:15:1045-1053.
Nakashima The application of bone morphogenic proteins to Dentaltissue engineering. (bone morphogenetic protein application to dental tissue engineering) NatureBiotechnology, Volume 21, No. 9,2003, the 1025-1032 page.
Nakatomi M, Morita I, Eto K, Ota MS.Sonic hedgehog signaling isimportant In tooth root development. (sound Hedgehog type signal is important in root development) J Dent Res 2006; 85:427-31.
Nakatsu M, Sainson R, Perez-del-Pulgar S, Aoto J, Aitkenhead M, Taylor K, Carpenter P, Hughes C, VEGF121 and VEGF 165 RegulateBlood Vessel Diameter Through Vascular Endothelial Growth FactorReceptor 2 in an In Vitro (in angiogenesis model, VEGF121 and VEGF 165 passes through VEGF to Angiogenesis Model. in vitro Receptor 2 regulates blood vessel diameter), Lab Invest 2003,83:12, page 1873.
National Institute for Dental and Craniofacial Research.StrategicPlan 2003-2008. (strategic plan 2003-2008) J Am Coll Dent 2003:70:43-55.
Nebahat D, Dilhan MK, Elvan B.Biocomposites ofnanohydroxyapatite with Collagen and poly vinyl alcohol. is (containing collagen protein and the biology of the nanometer hydroxyapatite of polyvinyl alcohol Complex) Coll Surf B 2006;48:42-49.
Ohazama A, Modino SA, Miletich I, Sharpe PT.Stem-cell basedtissue Engineering of murine teeth. (organizational project based on stem cell of Muridae tooth) J Dent Res 2004: 83:518-522.
Onishi T, Ishidou Y, Nagamine T, Yone K, Imamura T, KatoM, Sampath T K, ten Dijke P and Sakou T 1998 Distinct and overlappingpatterns of localization of bone morphogenetic protein(BMP)familymembers and a BMP type II receptor (during fracture healing in rats, bone morphogenetic protein (BMP) family becomes during fracture healing in rats. Different and the overlapping pattern of the localization of member and BMP type II receptor) Bone 22 605-12.
Owen M, Friedenstein AJ.Stromal stem cells:marrowderivedosteogenic Precursors. (stroma stem cell: the osteogenic precursor of bone marrow derived) CibaFound Symp 1988:136:42-60.
Owen ME, Cave J, Joyner CJ.Clonal analysis in vitro ofosteogenic Differentiation of marrow CFU-F. (the body outer clone analysis of the osteogenic differentiation of bone marrow CFU-F) J Cell Sci 1987:87:731-738.
Payne TL, Skobe Z, Yelick PC.Regulation of tooth developmentby the Noveltype I TGF β family member receptor Alk8. is (by novel type ITGF 'beta ' family member receptor The regulation of the tooth development of Alk8) J Dent Res 2001:80:1968-1973.
Peled, A., Grabovsky, V., Habler, L., Sandbank, J., Arenzana-Seisdedos, F., Petit, I., Ben-Hur, H., Lapidot, T. and Alon, R.The chemokine SDF-1 stimulates integrin-mediated arrest of CD34cells on vascular endothelium under shear Flow. (under shear flow, on blood vessel endothelium, chemotactic factor SDF-1 stimulates the capture of the CD34 cell of integrin-mediation) J.Clin.Invest.104,1199,1999.
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., Lider, O., Alon, R., Zipori, D. and Lapidot, T.Dependence (people does ofhuman stem cellengraftment and repopulation of NOD/SCID mice on CXCR4. Cell transplantation and NOD/SCID mice grow the dependency to CXCR4 again) Science 283,845,1999.
Peng Y, Kang Q, Cheng H, Li X, Sun M H, Jiang W, Luu H H, Park J Y, Haydon R C and He T C 2003 Transcriptional characterization ofbone morphogenetic proteins (BMPs)-mediated osteogenic signalling. (send out by the osteogenic signal of bone morphogenetic protein (BMP)-mediation Raw transcribes sign) J.Cell.Biochem.90 1149-65.
Perez MAA, Pitaru S, Fregoso AO, Gasga JR, Arzate H.Anticementoblastoma- derived protein antibody partially inhibitsmineralization on a cementoblastic (anti-cementoblastoma-derivative protein antibodies partly suppresses the ore deposit in cementoblast cell line to cell line. Change) J Struct Biol2003:143:1-13.
Perkins S, Fleischman RA.Stromal cell progeny of murin bonemarrow fibroblast colony-forming units are clonal endothelial-like cellsthat express (the stromal cell offspring of Muridae marrow fibroblast group-formation unit is for expressing for collagen IV and laminin. Clone's endothelioid cells of collagen protein IV and laminin,LN) Blood 1990:75:620-625.
Perrino MA, Yelick PC.Immunolocalization of Alk8 duringreplacement Tooth development in zebrafish. (at the immunolocalization replacing tooth development period Alk8 in Brachydanio rerio) Cells Tissues Organs 2004:176:17-27.
Persidis A.Tissue engineering. (organizational project) Nature Biotechnol 1999:17: 508-510。
Pietrokovski J, Massler M.Ridge remodeling after tooth extraction Inrats. (ridge after tooth is extracted is reinvented in rats) J.Dent.Res.461 (1967), the 222-231 page.
Pihlstrom BL, Michalowicz BS, Johnson NW.Periodontal diseases. (periodontal disease) Lancet 2005;366:1809-20.
Pitaru S, McCulloch CAG, Naryanan AS.Cellular origins anddifferentiation control mechanisms during periodontal development andwound Healing. J Periodontal Res (is grown and cell derived and differentiation control mechanism during wound healing) at periodontal 1994:29:81-94.
Plikus MV, Zeichner-David M, Mayer JA et al. Morphoregulation ofteeth: Modulating the number, size, shape and differentiation by tuningBmp activity. (the form regulation of tooth: regulate quantity, size, shape and differentiation by regulation Bmp activity) Evol Dev 2005;7: 440-57。
Polson AM.Periodontal regeneration. (periodontal regenerative) Chicago:Quintessence Publishing Co., 1994.
Quesenberry PJ, Becker P, Stewart FM.Phenotype of theengrafting stem Cellin mice. (transplanting the phenotype of stem cell in mice) Stem Cells.1998;16Suppl 1:33-5.
Qing C, Jian Y, Jianzhong B, Shenguo W.A novel porous cellsscaffold made of polylactide-dextran blend by combining phase-separationand particle Leaching techniques. (by being separated and the combination of granule leaching-out technique, is prepared by polylactide-glucosan blend Novel porous cytoskeleton) Biomaterials 2002;23:4483-4492.
Quinones CR, Caffesse RG.Current status of guided tissueregeneration. (present situation of the tissue regeneration of guiding) Periodontal 20001995:9:55-68.
Rahaman MN, Mao JJ.Stem cell-based composite tissue constructsfor Regenerative medicine. (for the complex histological structure based on stem cell of regenerating medicine) Biotechnol Bioeng 2005;91:261-84.
Rao MS.Multipotent and restricted precursors in the central Nervoussystem. (multiple-effect and limited precursor in central nervous system) Anat Rec 1999:257:137-148.
Rezwan K, Chen Q, Blaker J.Biodegradable and bio active porouspolymer/ Inorganic composite scaffolds for bone tissue engineering. (for bone tissue engineer can Biodegradable and bioactivity, porous polymer/inorganic complex support) Biomaterials 2006;27:3413-3431.
Rich J, Jaakkola T, Tirri T.In vitro evaluation of polye-caprolactone- Co-DL-lactide/bioactive glass composites. (e-caprolactone-DL-lactide copolymer/bioactivity glass The in-vitro evaluation of glass complex) Biomaterials 2002;23:2143-2150.
Ripamonti U, Reddi AH.Tissue engineering, morphogenesis, andregeneration Of the periodontal tissues by bone morphogenetic proteins. (passes through bone morphogenetic protein The organizational project of periodontal tissue, form occur and regeneration) .CritRev Oral Biol Med 1997:8:154-163.
Rouabhia M, Ross G, Page N and Chakir J 2002 Interleukin-18 andgamma interferon production by oral epithelial cells in response toexposure to Candida albicans or lipopolysaccharide stimulation. (in response to be exposed to Candida albicans or Fat polysaccharide stimulates, and produces IL-1 8 and IFN-γ by mouth epithelial cells) Infect.Immun.70 7073-80。
Rubio D, Garcia-Castro J, Martin MC, de la Fuente R, Cigudosa JC, Lloyd AC, Bernad A.Spontaneous human adult stem celltransformation. (spontaneous people's adult stem cell Convert) Cancer Res 2005:65:3035-3039 [corrigenda is in Cancer Res 2005:65:4969].
Rutherford RB, Ryan ME, Kennedy JE, Tucker MM, CharetteMF.Platelet- derived growth factor and dexamethasone combined with acollagen matrix induce Regeneration of the periodontium in monkeys. is (with the platelet of collagen matrices combination-derivative Somatomedin and dexamethasone in monkey, induce paradenlal tissue regeneration) J Clin Periodontal 1993:20:537- 544。
Sainio K, Raatikainen-Ahokas A.Mesonephric kidney-stem cellfactory?In ( Kidney-stem cell factory?) Int J Dev Biol 1999:43:435-439.
Saito N and Takaoka K 2003 New synthetic biodegradable polymers asBMP (the new synthesis as the BMP carrier for bone tissue engineer can for carriers for bone tissue engineering. Biodegradable polymer) Biomaterials 24 2287-93.
Saito N, Okada T, Toba S, Miyamoto S, Takaoka K (1999) Newsynthetic Absorbable polymers as BMP carriers:plastic properties ofpoly-D, L-lactic Acidpolyethylene glycol block copolymers. (the new absorbable polymerization of synthesis as BMP carrier Thing: poly-D, the plastic property of Pfansteihl polyethyleneglycol block copolymer) J Biomed Mater Res 47,104-110.
Sampath T K, Coughlin J E, Whetstone R M, Banach D, Corbett C, Ridge R J, Ozkaynak E, Oppermann H and Rueger D C 1990 Bovineosteogenic protein is composed Of dimers of OP-1 and BMP-2A, twomembers of the transforming growth factor- (cattle osteogenic albumen is by OP-1's and BMP-2A (two members of conversion growth factor-β Superfamily) for beta superfamily. Dimer forms) J.Biol.Chem.26513198-205.
Santos E, Badin S, Shenker B, Shapiro I, Ducheye P, Si-Ca-Pxerogels and bone morphogenetic protein act synergistically on rat stromalmarrow eell (Si-Ca-P xerogel and bone morphogenetic protein are to rat substrate Bone Marrow Cells In Vitro for differentiation in vitro. Break up synergism) J Biomed Mater Res 41,87-94.
Schantz J, Chim H, Whiteman M.Cell Homing in TissueEngineering:SDF-1 Mediates Site-Directed Homing of MesenchymalStem Cells within Three- Dimensional Polycaprolactone Scaffolds. (the cell playback in organizational project: SDF-1 mediates mesenchyme The playback of stem cell position-guiding in three-dimensional polycaprolactone support) Tissue Engineering volume 2007: the 13: 11:2615-2624.
Schantz, J.T. and Ng, (main people is thin for K.W.A Manual for Primary Human CellCulture. Born of the same parents' culture handbook) New Jersey:World Scientific, 2004.
Schantz, J.T., Hutmacher, D.W., Chim, H., Ng, K.W., Lim, T.C. and Teoh, S.H.Induction of ectopic bone formation by using humanperiosteal cells in Combination with a novel scaffold technology. is (by people's periosteum cell and New-support technology groups Conjunction makes for induced ectopic bone formation) Cell Transplant.11,125,2002.
Scott, L.J., Clarke, N.W., George, N.J., Shanks, J.H., Testa, N.G. and Lang, S.H.Interactions of human prostatic epithelial cells withbone marrow Endothelium: binding and invasion. (human prostatic epithelial cell and the interaction of marrow endothelial: bonding And invade) Br.J.Cancer 84,1417,2001.
Seale P, Rudnicki MA.A new look at the origin, function, andstem-cell " Status of muscle satellite cells. (origin of muscle satellite cell, function and stem cell situation new look) Dev Biol 2000:218:115-124.
Seo BM, Miura M, Gronthos S et al. Investigation of multipotentpostnatal Stem cells from human periodontalligament. is (from grinding of the people pericemental multiple-effect stem cell day after tomorrow Study carefully) Lancet 2004;364:149-55.
Sharpe PT, Young CS.Test-tube teeth. (test tube tooth) Sci Am 2005;293:34-41.
Shi S, Bartold PM, Miura M, Seo BM, Robey PG, GronthosS (2005) The efficacy Of mesenchymal stem cells to regenerate and repairdental structures. (do by mesenchyme Cell makes tooth structure regeneration and the effect repaired) OrthodCraniofac Res 8:191-199.
Shi S, Gronthos S, Chen S, Reddi A, Counter CM, Robey PG, Wang CY.Bone formation by human postnatal bone marrow stromal stemcells is enhanced by Telomerase expression. (Telomerase Expression strengthens the bone formation by the people's bone marrow stroma stem cell day after tomorrow) Nat Biotechnol.2002 Jun;20 (6): 587-91.
Shi S, Gronthos S.Perivascular niche of postnatal mesenchymal Stemcells in human bone marrow and dental pulp. (in people's bone marrow and dental pulp, the day after tomorrow, did by mesenchyme The blood vessel week microhabitat of cell) J Bone Miner Res 2003:18:696-704.
Shi S, Robey PG, Gronthos S.Comparison of human dental pulp andbone Marrow stromal stem cells by cDNA microarray analysis. (is come by cDNA microarray analysis Relatively people's dental pulp and bone marrow stroma stem cell) Bone 2001:29:532-539.
Shieh SJ, Vacanti JP.State-of-the-art tissue engineering:from Tissueengineering to organ building. (field of tissue engineering technology situation: build from organizational project to organ) Surgery 2005 137:1-7.
Shimizu Y. edits Tissue Engineering for Therapeutic Use2.Tokyo at Ikada Y: Elsevier, 1998;The Tissue engineering for softtissues. (tissue for soft tissue in 119-22 Engineering).
Shin H, Jo S, Mikos AG.Biomimetic materials for tissueengineering. (is used for The biomimetic material of organizational project) Biomaterials 2003;24:4353-4364.
Simmons PJ, Torok-Storb B.Identification of stromal cellprecursors in Human bone marrow by a novel monoclonal antibody, STRO-1. (passes through novel monoclonal antibody STRO-1 differentiates stromal cell precursor in people's bone marrow) Blood 1991:78:55-62.
Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, Jensen TG, Kassem M.Telomerase expression extends theproliferative life-span And maintains the osteogenic potential of humanbone marrow stromal cells. (end Granzyme is expressed and is extended proliferative lifespan and keep the osteogenic potentiality of human bone marrow substrate cell) Nat Biotechnol 2002:20: 592-596。
Sittinger M, Bujia J, Rotter N, Reitzel D, Minuth WW, Burmester GR.Tissue Engineering and autologous transplant formation:practical approaches with Resorbable biomaterials and new cell culturetechniques. (organizational project and autotransplantation shape Become: use can resorbent biomaterial and new cell culture technology put into practice method) Biomaterials 1996:17: 237-242。
Slavkin HC, Bringas P Jr, Bessem C, Santos V, Nakamura M, Hsu MY, Snead ML, Zeichner-David M, Fincham AG.Hertwig ' sepithelial root sheath differentiation and initial cementum and boneformation during long-term organ culture of Mouse mandibular firstmolars using serumless, chemically defined medium. (use The chemically defined culture medium of serum-free, during the Term Organ of mice lower jaw first molar cultivates, Hertwig epithelial root sheath Differentiation and initial stage cementum and bone formation) J Periodontal Res 1989:24:28-40.
Smith AJ, Murray PE, Sloan AJ, Matthews JB, Zhao S.Transdentinalstimulation of tertiary dentinogenesis. (stinging through dentine of the 3rd dentine generation Swash) AdvDent Res 2001:15:51-54.
Smith AJ.Tooth tissue engineering and regeneration-a translationalvision!(dental tissue engineering and regeneration-movement conception!) J Dent Res 2004:83:517.
Sodek J.A new approach to assessing collagen turnover by using amicroassay.A highly efficient and rapid turnover of collagen in Ratperiodontal tissues. (evaluates the new method of collagen protein upset by using microcosmic to measure.At rat tooth In organizing in week, the height of collagen protein efficiently and quickly overturns) Biochem J1976:160:
Sonoyama W, Liu Y, Fang D, Yamaza T, Seo BM, Zhang C, Liu H, Gronthos S, Wang C, Shi S, Wang S, Mesenchymal StemCell-Mediated Functional Tooth Regeneration in Swine. (the functional regeneration of tooth of mescenchymal stem cell-mediation in pig), PLoS ONE.2006;1 (1): e79.
Steele-Perkins G, Butz KG, Lyons GE et al. Essential role forNFI-C/CTF Transcription-replication factor in tooth root development. (in root development NFI- C/CTF transcribes-basic role of replicator) and Mol Cell Biol2003;23:1075-84.
Sternlicht M D and Werb Z 2001 How matrix metalloproteinasesregulate Cell behavior. (how matrix metalloproteinase regulates cell behavior) Annu.Rev.Cell Dev.Biol.17 463- 516。
Stock UA, Vacanti JP.Tissue engineering:current state andprospects. (group Weaver's journey: present situation and prospect) Annu Rev Med 2001:52:143-151.
Stosich MS, Bastian B, Marion NW, Clark PA, Reilly G, Mao JJ, Vascularized adipose tissue grafts from human mesenchymal stem cellswith bioactive cues And microchannel conduits. (uses biological activity clue and microchannel conduit, by the blood of human mesenchymal stem cell The adipose tissue transplantation of pipe) Tissue Eng.2007 Dec;13 (12): 2881-90.
Sumikawa DA, Marshall GW, Gee L, Marshall SJ.Microstructureof primary Tooth dentin. (microstructure of primary tooth dentin) Pediatr Dent 1999:21:439-444.
Susan Liao, Kazuchika T.Human neutrophils reaction to thebiodegraded nano-hydroxyapatite/collagen andnano-hydroxyapatite/collagen/poly L-lactic (human neutrophil is to biodegradable nano hydroxyapatite/collagen albumen and nano-hydroxy-apatite for acid composite. The reaction of stone/collagen protein/poly (l-lactic acid) complex) J Biomed Mater Res 2006;76A:820-825.
Suzuki Y, Tanihara M, Suzuki K, Saitou A, Sufan W and NishimuraY 2000 Alginate hydrogel linked with synthetic oligopeptide derived fromBMP-2 allows Ectopic osteoinduction in vivo. (the Alginate hydrogel energy being connected with the synthesis of oligonucleotides peptide derived from BMP-2 Internal dystopy self-bone grafting) J.Biomed.Mater.Res.50 405-9.
Sweeney TM, Opperman LA, Persing JA, Ogle RC (1995) Repair ofcritical size Rat calvarial defects using extracellular matrix protein gels. (uses extracellular matrix Critical dimension rat calvarial defect repaired by protein gel) J Neurosurg 83,710-715.
Sylvain D, Eduardo S, Antoni PT.Freeze casting ofhydroxyapatite Scaffolds for bone tissue engineering. (water by the freezing for the hydroxyapatite scaffold of bone tissue engineer Casting) Biomaterials 2006;27:5480-5489.
Taba M Jr, Jin Q, Sugai JV, Giannobile WV.Current concepts inperiodontal Bioengineering. (the current idea in periodontal biological engineering) OrthodCraniofac Res 2005:8:292-302.
Tabata Y.Significance of release technology in tissueengineering. ( The importance of release tech in organizational project) Drug Discov Today2005;10:1639-46.
Taguchi Y, Yamamoto M, Yamate T, Lin S C, Mocharla H, DeTogni P, Nakayama N, Boyce B F, Abe E and Manolagas S C 1998Interleukin-6-type cytokines stimulate Mesenchymal progenitordifferentiation toward the osteoblastic lineag. (leukocyte Between interleukin-6-cytokines stimulate mesenchyme remote ancestor towards osteoblast pedigree break up) Proc.Assoc.Am.Physicians 110 559-74。
Tan KH, Chua CK, Leong KF.Scaffold development usingselective laser Sintering of polyetheretherketone-hydfoxyapatitebiocomposite blends. (uses and selects The stent development of property laser sintered polyether-ether-ketone-hydroxylapatite biology compound blend) Biomaterials 2003;24: 3115-3123。
Tardif F, Ross G and Rouabhia M 2004 Gingival and dermalfibroblasts produce interleukin-1 beta converting enzyme andinterleukin-1 beta but not Interleukin-18 even after stimulation withlipopolysaccharide. (gingiva and skin fibroblast Dimension cell produces IL-1 'beta ' converting emzyme and IL-1 β, but does not produce IL-1 8, i.e. Make after using fat polysaccharide to stimulate) J.Cell.Physiol.198 125-32.
Thesleff I, Aberg T.Molecular regulation of tooth development. (send out by tooth The molecular regulation educated) Bone 1999:25:123-125.
Thesleff I, Keranen S, Jernvall J.Enamel knots as signaling Centerslinking tooth morphogenesis and odontoblast differentiation. (tie by enamel Connect dental morphology as signal generative center to occur and odontoblast differentiation) Adv Dent Res2001:15:14-18.
Thesleff I, Sharpe P.Signalling networks regulating dentaldevelopment. (signal network of regulation tooth development) Mech Dev 1997;67:111-23.
Thesleff I, Vaahtokari A, Kettunen P, Aberg T.Epithelialmesenchymal Signaling during tooth development. (the epithelium mesenchyme signal during tooth development occurs) Connect Tissue Res 1995:32:9-15.
Thesleff I.Epithelial-mesenchymal signalling regulating Toothmorphogenesis. (the epithelial-mesenchymal signal that regulation dental morphology occurs occurs) J Cell Sci2003;116: 1647-8。
Thesleff I.The genetic basis of tooth development and dentaldefects. (tooth development and the gene basis of defects in teeth) Am J Med Genet A 2006;140:2530-5.
Thies R S, Bauduy M, Ashton B A, Kurtzberg L, Wozney J M and Rosen V 1992 Recombinant human bone morphogenetic protein-2 inducesosteoblastic (recombinant human bone morphogenesis protein-2 induced osteogenesis is thin for differentiation in W-20-17 stromal cells. Born of the same parents break up in W-20-17 stromal cell) Endocrinology130 1318-24.
Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD.Human mesenchymal stem cells differentiate to a cardiomyocytephenotype in the adult murine Heart. (human mesenchymal stem cell is divided into cardiac myocytic phenotype in adult Muridae heart) Circulation 2002:105: 93-98。
Tsuji K, Ito Y and Noda M 1998 Expression of thePEBP2alphaA/AML3/CBFAl gene is regulated by BMP4/7 heterodimerand its overexpression suppresses type I collagen and osteocalcin geneexpression in osteoblastic and nonosteoblastic Mesenchymalcells. (expression of PEBP2alphaA/AML3/CBFAl gene is regulated by BMP4/7 heterodimer, and And its overexpression suppresses I-type collagen and the Bone Gla protein gene table in osteoblast and non-osteoblast mesenchymal cell Reach) Bone 2287-92.
Tucker A, Sharpe P.The cutting-edge of mammalian development:how the Embryo makes teeth. (forward position of mammalian development: how embryo manufactures tooth) Nat Rev Genet 2004;5: 499-508。
Tummers M, Thesleff I (2003) Root or crown: a developmentalchoice orchestrated by the differential regulation of the epithelial stem cellniche In the tooth of two rodent species. (root or hat: by difference in the tooth of two kinds of rodent species Property regulation epithelial stem cell microhabitat, elaborately planned growth select) Development 130:1049-1057.
US Department of Health and Human Services.Oral health inAmerica:a Report of the surgeon general. (oral health of the U.S.: surgeon's comprehensive report) Rockville, MD: US Department of Health and Human Services, NIDCR, NIH, 2000.
Vacanti MP, Leonard JL, Dore B, Bonassar LJ, Cao Y, Stachelek SJ, Vacanti JP, O ' Connell F, Yu CS, Farwell AP, VacantiCA.Tissue-engineered spinal cord. (group Knit-the spinal cord of through engineering approaches) Trahsplant Proc2001:33:592-598.
Varghese S and Canalis E 1997 Regulation of collagenase-3 by Bonemorphogenetic protein-2 in bone cell cultures. (passes through Bones morphology in bone cell cultures Albumen-2 is occurred to regulate Collagenase-3) Endocrinology 138 1035-40.
Van Diik LJ, Schakenraad JM, van der Voort HM, BusscherHJ.Cell seeding (cell of periodontal ligament fibroblasts connects of periodontal ligament fibroblasts.A pilot study. Kind. a preliminary study) J Clin Periodontal 1991:18:196-199.
Van der Heyden C, Allizard F, Sire JY, Huysseune A.Toothdevelopment in Vitro in two teleost fish, the cichlid Hemichromisbimaculatus and the cyprinid Danio rerio. (two kinds of bony fishes: Callichthyidae hemichromis bimaculatus and the ectogenesis of Cyprinidae Brachydanio rerio Tooth) .Cell Tissue Res 2005:321:375-389.
Van der Heyden C, Huysseune A.Dynamics of tooth formation Andreplacement in the zebrafish (Danio rerio) (Teleostei, Cyprinidae). (Brachydanio rerio The kinetics that (Danio rerio) (Teleostei, Cyprinidae) Tooth is formed and replaces) DevDyn 2005:219:486- 496。
Van der Heyden C, Wautier K, Huysseune A.Tooth succession in Thezebrafish (Danio rerio). (the tooth succession in Brachydanio rerio (Danio rerio)) Arch OralBiol 2001:46:1051-1058.
Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC Signalingfactors in stem The cell-mediated repair of infarcted myocardinm. (reparation in the myocardium stem cell-mediation of infraction In signal factor) J MoI Cell Cardiol.2005 Aug;39 (2): 363-76.
Vavidovitch Z.Bone metabolism associated with tooth eruption Andorthodontic tooth movement. (bone metabolism relevant to tooth eruption and orthodontics teeth training) J Periodontal 1979:50 (4Spec No): 22-29.
Viljanen VV, Lindholm TC, Gao TJ, Lindholm TS (1997) Lowdosage of native Allogeneic bone morphogenetic protein in repair of sheepcalvarial defects. ( In the reparation of sheep braincap defect, the local allogene bone morphogenetic protein of low dosage) Int J Oral Maxillofac Surg 26,389-393.
Wei Jie, Li Yubao.A study on nano-composite of hydroxyapatiteand Polyamide. the J MaterSci 2003 (to hydroxyapatite and the research of the nano-complex of polyamide);38:3303- 3306。
Woodfield, T.B., C.A.Van Blitterswijk et al. (2005). " Polymerscaffolds fabricated with pore-size gradients as a model for studying thezonal Organization within tissue-engineered cartilage constructs. (uses hole-size gradient system The polymer support made is as the model studying banded structure at the cartilage of tissue-through engineering approaches in constructing) " Tissue Eng 11 (9-10): 1297-311.
Woodfield, T.B., J.Malda et al. (2004). " Design of porousscaffolds for cartilage tissue engineering using a three-dimensionalfiber-deposition Technique. (three-dimensional fiber-deposition technique is used, for the design of cartilage tissue engineered porous support) " Biomaterials 25 (18): 4149-61.
Wozney JM, Rosen V, Byrne M, Celeste AJ, Moutsatsos I, Wang EA.Growth Factors influencing bone development. (affecting the somatomedin of bone development) J Cell Sci Suppl.1990;13:149-156.
Wynn, R.F., Hart, C.A., Corradi-Perini, C, O ' Neill, L., Evans, C.A., Wraith, E., Fairbairn, L.J. and Bellantuoho, I.A smallproportion of mesenchymal stem cells strongly expresses functionalityactive CXCR4 receptor capable of promoting (the mescenchymal stem cell strong expression of small scale can promote that the function migrating to bone marrow is lived to migration to bonemarrow. Property CXCR4 receptor) Blood 104,2643,2004.
Xiao Y, Qian H, Young WG, Bartold PM.Tissue engineering forbone regeneration using differentiated alveolar bone cells in collagenscaffolds. (using the osteanagenesis organizational project of the alveolar bone cell of differentiation in collagen scaffold) Tissue Eng 2003:9:1167- 1177。
Yamada S, Murakami S, Matoba R, Ozawa Y, Yokokoji T, NakahiraY, Ikezawa K, Takayama S, Matsubara K, Okada H.Expression profileof active genes in human Periodontal ligament and isolation of PLAP-1, anovel SLRP family gene. is (at people's tooth The expression and distribution of active gene and PLAP-1 in week ligament, a kind of novel SLRP family gene, separation) Gene 2001:275: 279-286。
Yamashiro T, Tummers M, Thesleff I.Expression of bonemorphogenetic Proteins and Msx genes during root formation. (root formed during bone morphogenetic protein and Msx The expression of gene) J Dent Res 2003;82:172-6.
Yelick PC, Schilling TF.Molecular dissection of Craniofacialdevelopment using zebrafish. (molecule using the Craniofacial growth of Brachydanio rerio is dissected) CritRev Oral Biol Med 2002:13:308-322.
Yelick PC, Vacanti JP.Bioengineered teeth from tooth bud cells. is (from tooth The Bioengineered tooth of flower bud cell) Dent Clin North Am 2006;50:191-203, viii.
Yeong W-Y, Chua C-K.Rapid prototyping in tissue engineering:Challenges And potential. (rapid prototype manufacturing in organizational project: challenge and potentiality) Trends Biotechnol 2004; 22:643-652.
Young CS, Abukawa H, Asrican R et al. Tissue-engineered hybridtooth and Bone. (the mixing tooth and bone of tissue-through engineering approaches) Tissue Eng 2005;11:1599-610.
Young CS, Abukawa H, Asrican R, Ravens M, Troulis MJ, KabanLB, Vacanti JP, Yelick PC (2005) Tissue-engineered hybrid tooth andbone. (tissue-through engineering approaches mix tooth And bone) Tissue Eng11:1599-1610.
Young CS, Kim S-W, Taylor R, Vacanti JP, Bartlett JD, Yelick PC.Developmental analysis and three-dimensional computermodeling of tooth Crowns grown on biodegradable polymer scaffolds. is (raw on biodegradable polymer support The Analysis on development of long corona and three-dimensional computer modeling) Arch Oral Biol 2005:50:259-265.
Young CS, Terada S, Vacanti JP, Honda M, Bartlett JD, YelickPC.Tissue Engineering of complex tooth structure on biodegradablepolymer scaffolds. ( The organizational project of tooth structure complicated on biodegradable polymer support) J Dent Res 2002:81:695-700.
Zhang W, Walboomers XF, Wolke JG, Bian Z, Fan MW, JansenJA.Differentiation Ability of rat postnatal dental pulp cells in vitro. (external point of the rat pulp cells day after tomorrow Change ability) Tissue Eng 2005:11:357-368.
Zhao J, Guo LY, Yang XB, Weng J.Preparation of bioactive porousHA/PCL Composite scaffolds. (preparation of bioactivity, porous HA/PCL complex support) Applied Surface Science volume 2008: the 255: the 5th phase: part 2: 2942-2946.
Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC.Human bone marrow stem cells exhibit neural phenotypes andameliorate neurological Deficits after grafting into the ischemic brain ofrats. (is transplanting the local entering rat After ischemic brain, people's bone marrow stem cell presents neural phenotypes and improves neurological deficit) Exp Neural 2002:174:11- 20。
Zhao M, Jin Q, Berry JE, Nociti FH Jr, Giannobile WV, SomermanMJ.Cementoblast delivery for periodontal tissue engineering. is (for periodontal The cementoblast of organizational project delivers) J Periodontol 2004:75:154-161.
Zhu W, Rawlins B A, Boachie-Adjei O, Myers E R, ArimizuJ, Choi E, Lieberman J R, Crystal R G and Hidaka C 2004 Combinedbone morphogenetic protein-2 and-7 gene transfer enhances osteoblasticdifferentiation and spine fusion in a (in rodent model, bone morphogenesis protein-2 and the transfer of-7 genes of combination is enhanced to osteocyte to rodent model. Differentiation and spinal fusion) J.Bone Miner.Res.192021-32.
In view of above description, it can be seen that achieve some advantages of the present invention and achieve further advantage.

Claims (20)

1. an acellular mammalian tooth shape support, described support comprises
Host material;With
Compositions, it comprises CXCL12 (SDF1) and BMP-7 (BMP-7);
Wherein, described compositions is chemotaxis and osteogenic, one-tenth dentine, one-tenth enamel or one-tenth cementum,
In described compositions is distributed to the host material of tooth tooth shape support or on;
When contacting with the dental tissue comprising CFU-GM, described compositions lures that CFU-GM moves in tooth tooth shape support into;And
Tooth tooth shape support does not comprise living cells before implantation.
Support the most according to claim 1, wherein said support has people's front tooth, people's canine tooth, people's bicuspid or the shape of people's molar Shape.
Support the most according to claim 1, wherein said compositions is encapsulated in slow release encapsulation vehicle and is distributed to tooth shape and props up In the host material of frame or on.
Support the most according to claim 1, wherein said compositions also includes the somatomedin (PDGF) of platelet-derivative, interior Skin cell growth factor (ECGF), conversion growth factor-β l (TGF-β l), epidermal growth factor (EGF), hepatocyte growth factor (HGF), the bone morphogenetic protein in addition to BMP-7 (BMP), TGF-β, GDF (GDF), insulin-like growth factor Son-1 (IGF1), VEGF (VEGF), fibroblast growth factor (FGF), dentine matrix albumen, dentine saliva Gland albumen, bone salivary gland albumen, amelogenin or integrin.
Support the most according to claim 1, wherein chemotaxis somatomedin is SDF1, and osteogenic, one-tenth dentine, one-tenth enamel Property or become cementum somatomedin be BMP-7.
Support the most according to claim 5, wherein:
I () BMP-7 is 10ng/g support-1000 μ g/g support in the bracket, and SDF1 be in the bracket 10ng/g support- 1000 μ g/g supports;Or
(ii) BMP-7 is about 100 μ g/g supports in the bracket, and SDF1 is about 100 μ g/g supports in the bracket.
Support the most according to claim 6, wherein said host material comprises bone conduction material.
Support the most according to claim 7, wherein said host material comprises the mixture of ε-polycaprolactone and hydroxyapatite.
Support the most according to claim 1, described support comprises:
Diameter is between 50-500 μm, or the microchannel of 200 μm;With
Gel, in wherein gel is introduced into microchannel, and described chemotaxis and osteogenic, becomes dentine, becomes enamel or become tooth Sclerotin compound embeds in this gel.
Support the most according to claim 1, described support comprises atresia corona.
11. supports as claimed in one of claims 1-10, described support comprises selected from two or more following features:
I () described support has people's front tooth, people's canine tooth, people's bicuspid or the shape of people's molar;
(ii) in described compositions is distributed to the host material of tooth tooth shape support in being encapsulated in slow release encapsulation vehicle or on;
(iii) described compositions also include the somatomedin (PDGF) of platelet-derivative, endothelial cell growth factor (ECGF) (ECGF), Conversion growth factor-β l (TGF-β l), epidermal growth factor (EGF), hepatocyte growth factor (HGF), bone shape in addition to BMP-7 State generation albumen (BMP), TGF-β, GDF (GDF), insulin-like growth factor-i (IGF1), blood vessel endothelium are raw The long factor (VEGF), fibroblast growth factor (FGF), dentine matrix albumen, dentine salivary gland albumen, bone salivary gland albumen, tooth Glaze albumen or integrin;
(iv) chemotaxis somatomedin is SDF1, and osteogenic, one-tenth dentine, one-tenth enamel or one-tenth cementum somatomedin For BMP-7;
V () BMP-7 is 10ng/g support-1000 μ g/g support in the bracket, and SDF1 be in the bracket 10ng/g support- 1000 μ g/g supports;
(vi) BMP-7 is about 100 μ g/g supports in the bracket, and SDF1 is about 100 μ g/g supports in the bracket;
(vii) described host material comprises bone conduction material;
(viii) described host material comprises the mixture of ε-polycaprolactone and hydroxyapatite;
(ix) described host material comprises 80% weight polycaprolactone and the mixture of 20% weight hydroxyapatite;
X () described support comprises diameter microchannel between 50-500 μm;
(xi) described support comprises the microchannel of a diameter of 200 μm;
(xii) described support comprises microchannel and gel, and wherein said gel is introduced in microchannel, and described chemotaxis with become Bone, one-tenth dentine, one-tenth enamel or one-tenth cementum compound embed in this gel;
(xiii) described support comprises atresia corona;And
(xiv) described support comprises the microchannel of a diameter of 200 μm, and described microchannel comprises the glue being incorporated in described microchannel Former protein gel, the slow release encapsulation vehicle encapsulating described compositions is embedded into the collagen gel being introduced in microchannel In;Described compositions comprises the BMP-7 that concentration is 100ng/ml gel and the SDF1 that concentration is 100ng/ml gel, and described Frame comprises atresia corona.
12. support according to claim 11, wherein said bone conduction material is hydroxyapatite.
13. supports according to claim 1, wherein said host material comprises 80wt% ε-polycaprolactone and 20wt% hydroxyl phosphorus Lime stone.
14. supports according to claim 9, wherein said gel is collagen gel.
15. supports as claimed in one of claims 1-10 are for lacking the goods of tooth in the mouth for the treatment of mammal Purposes in manufacture, wherein absence of tooth and in mouth disappearance tooth position there is alveolus, wherein:
Described support has in shape the implanted alveolus of losing tooth;And
Modeled by the tooth that computer-aided design (CAD) is disappearance, and synthesize described support with bioplotter;Or
Described support has a shape of people's first molar, and to but second mortar of opposite side at mouth similar with first molar Tooth carries out CT scan, and CAD utilizes the CT scan data of second molar to design described support.
The method of the tooth scaffold any one of 16. manufacturing claims 1-10, described method comprises:
Manufacture the support of mammalian tooth shape;With
By at least one chemotaxis compound and at least one osteogenic, become dentine, become enamel or become cementum chemical combination Thing introduces described support.
17. methods according to claim 16, wherein said support is Acellular matrix.
18. methods according to claim 16, wherein said support is in being similar in mammal lack the shape of tooth.
19. methods according to claim 16, wherein said method also includes using computer-aided design (CAD) preparation disappearance The model of tooth also synthesizes described support with bioplotter.
20. methods according to claim 16, wherein said support has the shape of people's first molar and carries out being similar to first But the molar CT scan of second molar of the opposite side at face, wherein use the CAD quilt of the CT scan data of second molar For designing described support.
CN201080037027.8A 2009-06-17 2010-06-17 Tooth scaffold Expired - Fee Related CN102639081B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18787509P 2009-06-17 2009-06-17
US61/187875 2009-06-17
US35416410P 2010-06-11 2010-06-11
US61/354164 2010-06-11
PCT/US2010/039035 WO2010148229A1 (en) 2009-06-17 2010-06-17 Tooth scaffolds

Publications (2)

Publication Number Publication Date
CN102639081A CN102639081A (en) 2012-08-15
CN102639081B true CN102639081B (en) 2016-12-14

Family

ID=

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1658914A (en) * 2002-04-09 2005-08-24 艾斯特勒科技公司 Medical prosthetic devices having improved biocompatibility
CN101264341A (en) * 2008-04-11 2008-09-17 东华大学 Three-dimensional porous tissue engineering bracket material, preparation and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1658914A (en) * 2002-04-09 2005-08-24 艾斯特勒科技公司 Medical prosthetic devices having improved biocompatibility
CN101264341A (en) * 2008-04-11 2008-09-17 东华大学 Three-dimensional porous tissue engineering bracket material, preparation and application thereof

Similar Documents

Publication Publication Date Title
US8979534B2 (en) Tooth scaffolds
Chen et al. Periodontal tissue engineering and regeneration: current approaches and expanding opportunities
Lee et al. Three-dimensional printed multiphase scaffolds for regeneration of periodontium complex
Orti et al. Pulp regeneration concepts for nonvital teeth: from tissue engineering to clinical approaches
Liu et al. Advances of adipose-derived mesenchymal stem cells-based biomaterial scaffolds for oral and maxillofacial tissue engineering
Strobel et al. Induction of bone formation in biphasic calcium phosphate scaffolds by bone morphogenetic protein‐2 and primary osteoblasts
Zhao et al. Osteogenic media and rhBMP-2-induced differentiation of umbilical cord mesenchymal stem cells encapsulated in alginate microbeads and integrated in an injectable calcium phosphate-chitosan fibrous scaffold
Thein-Han et al. Calcium phosphate cement with biofunctional agents and stem cell seeding for dental and craniofacial bone repair
US20150335400A1 (en) Tooth scaffolds
TW200817019A (en) De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progenitor cells
Yang et al. Periodontal regeneration with nano-hyroxyapatite-coated silk scaffolds in dogs
CN101534747A (en) De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progenitor cells
He et al. Periodontal tissue engineering and regeneration
Levengood et al. Human endothelial colony forming cells undergo vasculogenesis within biphasic calcium phosphate bone tissue engineering constructs
Bousnaki et al. A review of in vivo and clinical studies applying scaffolds and cell sheet technology for periodontal ligament regeneration
Steindorff et al. Innovative approaches to regenerate teeth by tissue engineering
Patil et al. Tissue engineering of craniofacial tissues—A review
Link et al. Osteogenic properties of starch poly (ε‐caprolactone)(SPCL) fiber meshes loaded with osteoblast‐like cells in a rat critical‐sized cranial defect
Babo et al. The role of a platelet lysate-based compartmentalized system as a carrier of cells and platelet-origin cytokines for periodontal tissue regeneration
Chen et al. Periodontal tissue engineering
Zhou et al. Scaffolds of bioactive glass (Bioglass®) combined with recombinant human bone morphogenetic protein-9 (rhBMP-9) for tooth extraction site preservation
Zhang et al. Effect of 3-dimensional collagen fibrous scaffolds with different pore sizes on pulp regeneration
Eslaminejad et al. Mesenchymal stem cell-based bone engineering for bone regeneration
BAGHBAN et al. In vivo bone formation by canine mesenchymal stem cells loaded onto HA/TCP scaffolds: qualitative and quantitative analysis
CN102639081B (en) Tooth scaffold

Legal Events

Date Code Title Description
PB01 Publication
SE01 Entry into force of request for substantive examination
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20161214

Termination date: 20180617